Movatterモバイル変換


[0]ホーム

URL:


EP2498691A2 - Braid ball embolic device features - Google Patents

Braid ball embolic device features

Info

Publication number
EP2498691A2
EP2498691A2EP10785550AEP10785550AEP2498691A2EP 2498691 A2EP2498691 A2EP 2498691A2EP 10785550 AEP10785550 AEP 10785550AEP 10785550 AEP10785550 AEP 10785550AEP 2498691 A2EP2498691 A2EP 2498691A2
Authority
EP
European Patent Office
Prior art keywords
implant
braid
proximal
sleeve
band
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP10785550A
Other languages
German (de)
French (fr)
Other versions
EP2498691B1 (en
Inventor
Frank P. Becking
Nicholas C. De Beer
Siddharth Loganathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Nfocus Neuromedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nfocus Neuromedical IncfiledCriticalNfocus Neuromedical Inc
Publication of EP2498691A2publicationCriticalpatent/EP2498691A2/en
Application grantedgrantedCritical
Publication of EP2498691B1publicationCriticalpatent/EP2498691B1/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Definitions

Landscapes

Abstract

Embolic implants and methods of manufacture are disclosed. The implants may be used for occluding blood flow at endovascular sites. One use is in intracranial aneurysm emolization/occlusion and another in parent vessel occlusion (PVO) or sacrifice. Various features provide for improved use (e.g., regarding delivery, recapture, visualization and/or occlusion) and manufacturability.

Description

BRAID BALL EMBOLIC DEVICE FEATURES
BACKGROUND
[0001 ] Commonly-assigned U.S. Patent Application Serial No. 12/465,475 to Becking, et al. (also PCT/US2009/041313) describes a new class of braid-based embolization devices and delivery system interfaces. The implants may be used for occluding blood flow at endovascular sites. One use is in intracranial aneurysm embolization or occlusion and another in parent vessel occlusion (PVO) or sacrifice. Improvements to those devices are disclosed herein.
SUMMARY
[0002] Braid-ball devices formed with folded-over and folded-flat distal end are among the architectures described in Becking, et al. These architectures are the ones best suited for treating brain aneurysms. Distal marker approaches are described that are especially suited for such devices. In addition, proximal end finishing approaches are described that are suitable for these and the rest of the devices described in Becking et al. All of the features and technologies presented in Becking, et al. (U.S. Patent Application Serial No. 12/465,475 and PCT/US2009/041313) are incorporated herein by reference.
[0003] Regarding the distal marker approaches, one improvement comprises a tether to/for the distal marker included in the implant. Specifically, with the marker affixed adjacent the distal end of the implant (as in the folded-flat embodiments in the incorporated application), the length of the tether/tie extends to the proximal hub of the implant. It has a length set so that when the implant is compressed, the marker is pulled into alignment with the implant and/or catheter.
[0004] When a suture is employed for the tether, it can tie around the interior of the distal fold with minimal interference. However, it may be advantageous to use a wire ribbon (e.g., Pt or Nitinol) for other reasons.
[0005] Namely, a tether ribbon (especially when pre-formed into a "V" shape) can be threaded through the gap/hole and around as few as one wire from the braid. So- disposed, there is no interference with the compression of the distal end of the implant. What is more, spring action in the ribbon tether (whether comprising two filaments or trimmed to one after crimping, gluing, welding or otherwise affixing at least one marker) can help position the marker against/across the top of the implant when deployed. Such a ribbon can also contribute to marker radiopacity, thereby allowing a smaller marker size. [0006] Another option is to include fibers and/or other thrombus promoting material in connection with the tether. Whatever material option is selected and/or additional features are provided, the proximal end of the tether is advantageously captured between the layers of braid or between the braid and either one of optional inner or outer bands. It may be glued-in, affixed by welding or otherwise.
[0007] Yet another set of improvements concerns the manner in which the implant is finished. By "finished", what is meant is the manner in which the proximal side of the implant is managed to define a hub and/or delivery system detachment interface.
[0008] In one advantageous approach, in which use of an inner band is desired for interface with detachment system components (such as those described in the referenced application), processing is done with an elongate hypotube set within the braid. The hypotube (e.g., about 2-5 cm long) serves as a means to hold and manipulate an implant preform construct. In addition, when the tube is trimmed off (or when the final or near-final implant is trimmed off relative to the tube being held) the remaining portion of the hypotube within the implant (now the "inner band") defines the detachment interface lumen. Likewise - especially when a more radiopaque material such as Pt/Ir or CoCr is used for the tube, the same structure will improve and/or offer the requisite radiopacity at the proximal end of the implant.
[0009] In all, the approach (optionally characterized as a "sacrificial hypotube length" approach) is useful for gluing but may also be applied in a welding technique. In fact, it may be especially useful in the latter context by providing shielding from weld slag and deformation for the proximal aperture/port to be exposed by trimming the tube to define the inner band in the implant. Namely, after welding, a clean cut can be made (e.g., with a diamond saw, laser cutting, EDM, etc. - as above) and then any deburring (by mechanical action, etching, EP or otherwise) can be performed on the newly- exposed face as desired.
[0010] In conjunction with a sacrificial hypotube length approach for gluing, or the original gluing approach described in the referenced application, another advantageous option is offered by a different post-processing step. Namely, after an outer band is used at the proximal end of the implant to define an outer casting boundary for adhesive/glue (e.g., Loctite 4014), it then may be removed leaving the underlying glue casting in place. Outer band removal offers potential to reduce all of the height, diameter and appearance of the size of the proximal feature of the implant.
Accordingly, it may assist in developing a system with 0.021 " catheter crossing profile. [001 1 ] To facilitate removal, the band may advantageously comprise NiTi alloy (that naturally forms a passivation layer) or it may be coated or otherwise plated. A Titanium Nitride coating may be desirable. Spray mold release (e.g., 3M) or dip- coating in mold release may alternatively be employed to assist in slipping-off the band after adhesive application and curing. Otherwise, the band can be cut off the glue casting.
[0012] Another approach for achieving minimal implant hub diameter - while
maintaining necessary radiopacity - involves affixing a platinum band on top of an inner NiTi band (i.e., in a linear arrangement). The proximal/lower NiTi section can be easily welded to the NiTi braid in the ball (when so-constructed) and the Pt (including Pt/Ir and other alloys) provides an in-line radiopaque marker. The detachment system control and anchor wires are received through both bands. The bands may be attached (e.g., by welding, gluing or soldering) or merely associated with each other until detachment system wire removal. In either case, they may include interference fit, puzzle-piece or other groove or tongue-and-groove features to make or assist in making a connection between the bodies.
[0013] Another set of improvements concerns shaping the distal end of a "folded-flat" type implant. It may be provided with a flattened top. The flattened top derives from a flat formed in the round tooling over which the braid is shaped. The flat can be produced by milling about 0.010" off the form. This depth cut allows sufficient "table" for desired shaping and can be consistently applied across a range of implants sized from about 5 mm to 12 mm in diameter with little effect on the perceived shape. The resulting crease in the implant wire shaped by such a form offers an immediate advantage to implant deployment. With the flat placed so close to the distal end of the device, shape recovery of the bend/crease around the flattened top drives early opening of the implant when unsheathed (as compared to a situation where a crease formed around the flat is set further away - or none is provided).
[0014] Yet another set of implant improvements described herein augments the density of the ball. Stated otherwise, provision is made for an additional layer of braid material to further decrease the braid matrix porosity, and possibly do so without any increase in device crossing profile/delivery (micro)catheter compatibility.
[0015] These improvements involve a third layer of braid that is added to the two layers preferably already present in the folded-flat base implant architecture. In one variation, a third layer of braid is captured between the two layers and captured within the hub region, but trimmed proximal to the distal folded-over/flat section. In another variation, an inner layer is set within the envelope of the aforementioned two layers. It is advantageously attached to a distal end of the inner marker band (above/distal) to any outer marker band provided. As such, the braid's attachment will not increase the hub profile. To avoid any profile increase at the distal end of the implant, the inner layer will typically be trimmed so its compressed length is located proximal to the folded- over braid at the distal end of the implant when compressed. In its unconstrained form, the inner layer may simply define a cup. Alternatively, it may define a secondary ball shape. Such a ball shape may be substantially spherical or ovoid. One advantageous configuration further includes unterminated distal ends to the braid. The ends of the braid defining the inner ball may be secured in a band or welded together. So- configured they can offer another radiopaque marker feature within the ball. However, it may be preferred that the braid ends of the inner layer (in cup, ball form, or otherwise) are unterminated. As such, they may improve thrombus formation within the body of the implant.
[0016] Finally, delivery system improvements are described. The features described are "improvements" - as are the features noted above - in a contextual sense. For example, certain of the delivery system architectures may not be as space-efficient as others. Yet, such larger system(s) may be desirable for reason of reduced
manufacturing complexity and/or cost.
[0017] The subject implant and delivery devices, kits in which they are included,
methods of use and manufacture are all included within the scope of the present description. A number of aspects of such manufacture are discussed above. More detailed discussion is presented in connection with the figures below.
BRIEF DESCRIPTION OF THE FIGURES
[0018] The figures provided herein are not necessarily drawn to scale, with some
components and features exaggerated for clarity. Variations from the embodiments pictured are contemplated. Accordingly, depiction of aspects and elements of embodiments in the figures are not intended to limit the scope of the description.
[0019] In the figures, Figs. 1A and I B show an implant with a marker tether as
expanded and being compressed, respectively; Figs. 2A and 2B show the distal end and a side view of another tethered-marker embodiment, respectively; Fig. 3 is a detail view of a marker/tether subassembly; Fig. 4 diagrammatically illustrates the assembly in Fig. 3 set within an implant; Fig. 5 shows an implant preform prepared for proximal end finishing; Fig. 6 shows the proximal end welded; Figs. 7 shows an implant preform prepared for proximal end finishing according to another approach; Fig. 8 shows the proximal end cut and welded; Figs. 9A and 9B show implants employing alternative proximal end finishing approaches, with a detail view in Fig. 9B of a low-profile embodiment; Figs. 10A and 10B show additional proximal end radiopaque features as may be employed with various end-finishing approaches; Fig. 1 1 shows in implant formed with a distal flattened top; Fig. 12 shows implant forms for imparting an implant shape as shown in Fig. 1 1 across a number of different implants of a given size range; Figs. 13A and 13B, respectively, illustrate the operation of an implant shaped according to Fig. 1 1/12 as compared to one that is not; Figs. 14- 17 diagrammatically illustrate improved density implants as compared to the architecture presented in Fig. 4; Fig. 18 shows an overview of an implant/detachment system interface as may be employed in connection with the present invention; Figs. 19A-19E and 20A-20E illustrate the stages of operation (handle-side and implant-side, respectively) of the system shown in Fig. 1 8; Fig. 21 shows an optional improvement to the architecture of the same system; Figs. 22A and 22B show an alternative delivery system interface engaged and disengaged, respectively; Fig. 23 is an end-on view of the delivery system interface as pictured in Fig. 22B. Figs. 24A and 24B illustrate alternative end-on views of the configuration of a pusher shaft in the same system; Figs 25A and 25B show alternative delivery system interface options (engaged and disengaged, respectively) based on the pusher shaft configuration in Fig. 24B; Fig. 26 shows an alternative implant-side interface with a delivery system as presented in Figs. 25A and 25B; Fig. 27 shows an implant-side interface like that presented in Fig. 26 with an alternative pusher-side architecture; Figs. 28A and 28B show an alternative
engagement/disengagement interface for a system like that shown in Figs. 22A and 22B; Figs. 29 and 30 show yet another engagement/disengagement architecture for each of a braid-type implant and embolic coil, respectively.
DETAILED DESCRIPTION
Various exemplary embodiments are described below. Reference is made to these examples in a non-limiting sense,as it should be noted that they are provided to illustrate more broadly applicable aspects of the devices, systems and methods.
Various changes may be made to these embodiments and equivalents may be substituted without departing from the true spirit and scope of the invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein. [0021 ] To the extent any dimensions are stated in the summary or detailed description, such are intended to be merely examples and are not to limit the inventive subject matter unless explicitly recited in the claims.
[0022] Furthermore, the various features of the embodiments described herein are intended to be complement each other and are not intended to be purely alternatives unless stated so. In other words, features from one embodiment may be freely combined with features of another embodiment, as one of ordinary skill in the art will readily recognize, unless it is stated that those features are only to be used in the alternative. Applicants therefore intend this paragraph to provide written support for any present or future claim that recites features taken from different embodiments, should such not already be clear from the summary, detailed description, and claims.
[0023] Turning to the figures, Figs. 1A and I B show an implant 10. In Fig. 1 A, only the hub (not visible) of implant 10 is received within a sheath or catheter 2. Roughly 40% of implant 10 is received within sheath 2 in Fig. I B. A radiopaque marker 20 (e.g., a Pt band) is visible in both views. As in Becking, et al, and with further reference to Fig. 4, implant 10 includes a tie 22 positioned between braid layers 12 and 14 adjacent a distal fold 16 in the braid, which defines aperture 18 (also referred to herein as the hole or gap in the braid). Marker 20 is held by tie 22. Tie 22 may also assist in closing or limiting the size to which aperture 18 may open.
[0024] While tie 22 terminates adjacent marker 20 in Becking et al., it extends to
proximal hub 30 of implant 10 in the present description. The extension "tether" portions, or members, 24 so-provided operate to ensure axial alignment of marker 20 when implant 10 is captured (especially when re-capturing) in a catheter/sheath.
[0025] The length of tether member(s) 24 is therefore set such that slack is present when the implant is expanded (as shown in Fig. 1 A) and the slack is removed when the implant is fully compressed or tending thereto (as shown in Fig. I B).
[0026] Whereas the tie and/or tether member shown in Figs. 1A and I B is typically made of suture material, it may be made of any other biocompatible material including stainless steel, titanium, Nitinol (possibly wire that is martinistic at body temperature - commonly referred to as "'muscle wire"), and the like. When suture material is employed it can tie around the interior of distal fold 16 with minimal interference and be knotted at point 26 (see Fig. 1A) to easily secure the position of marker 20. The same approach may be accomplished with fine wire (e.g., 0.001 inch round wire.)
[0027] It may instead be advantageous to use a wire ribbon (e.g., Pt or Nitinol) for other reasons. A construction as detailed in the next figures was made using a superelastic NiTi ribbon with dimensions set at about 0.001 inches by about 0.003 inches.
A tether ribbon 22 heatset into a tight loop or "'V" shape was threaded through gap 20 and around as few as one wire from the braid at a distal end of implant 10 as shown in Fig. 4. So-disposed, tether ribbon 22 does not substantially interfere with compression of the distal end of the implant. What is more, spring action in the tether ribbon (whether comprising two filaments or trimmed to just one filament (as indicated by the broken line) after crimping, gluing, welding or otherwise affixing marker 20 as shown in Fig. 3) can help position marker 20 against (or across) the top of implant 10 when deployed, as shown in Figs. 2A and 2B. As for affixing the marker, it is notable that the paired ribbon sections, stacked upon each other, provide a good interface upon which to crimp marker 20 without drastically altering the marker's shape.
Also, the length of the tether may optionally be set in a general "question-mark" shape to match (or more closely match) the curvature of the implant when
unconstrained (e.g., as the tether appears in Fig. 4). Pre-shaping the tether to "match" (or approximately match) one or more implant sizes can help ensure predictable and similar performance of implants across a range of different implant sizes and compressions.
As stated above, another improvement to the subject implants concerns the manner of proximal end finishing. Fig. 5 shows an implant preform 60 prepared for proximal end finishing. Here, implant preform 60 such as prepared in Becking, et al. is prepared, leaving an additional overhang section 50 extending past a proximal marker band 32. In many respects, the setup resembles that shown in Fig. 13A of Becking et al. with the implant preform 60 including an inner NiTi tube 34 and the assembly set upon a mandrel 52. To maintain the position of the components as shown, glue (e.g., Loctite 4014) is applied. Even so, and referring also to Fig. 6, the hub region 30 can be welded effectively with a weld bead 54 incorporating the overhanging braid 50, inner tube 34 and at least tack-welding an outer Pt band 32. It is noteworthy that achieving such a near-optimal welding result through (or into) the glue stabilized braid was a surprising result. In other words, it was neither predictable nor expected by those of skill in the art of welding (laser or otherwise). In any case, the length of the braid overhang incorporated into weld 54 may vary depending on a number of factors including implant diameter, wire diameter, braid density, etc. As shown, the overhang is about 0.005 to about 0.010 inches in length. [0031] Another proximal end finishing approach is described in connection with Fig. 7.
Specifically, preform 62 is not trimmed and stabilized for welding as shown in Fig. 5. Rather, preform 62 is prepared upon an elongate hypotube 54. The hypotube body provides a means to hold the construct and stabilize its elongate "tail" section 56 of braid layer 12 and/or layer 14 (e.g., by a wrap 58) thereon.
[0032] With a narrow window defined (e.g., with about 0.010 to about 0.025 inches of
- preferably - exposed braid) laser energy is applied as indicated by the larger area. The energy is sufficient to weld the braid to the hypotube. The welding process does not, however, weld the hypotube to the optional underlying mandrel 52.
[0033] After such welding, the majority of the length of hypotube 54 is "sacrificed". It is trimmed-off to define the inner band 34 of the implant as shown in Fig. 8. This inner band may provide some or all of the radiopacity required in the hub region 30.
Flowever an outer band (especially if it comprises Ft) can be tack welded to the braid as indicated by the arrow Z in Fig. 7.
[0034] Irrespective of whether an outer marker band is included, Fig. 8 illustrates an advantage of the finishing approach, namely, the avoidance of weld bead flow artifacts associated with surface tension at the end of a body (as seen in Fig. 6). Rather, the weld 64 is neatly faced and the inner lumen of the remaining band 34 de-burred and/or reamed. Both actual and apparent hub size can be minimized accordingly.
[0035] Figs. 9A and 9B illustrate another advantageous proximal end finishing
approach for minimizing proximal hub size. Fig. 9A shows an implant with an outer marker band 32 as it will generally appear as affixed by glue or welding. In instances where such a band is affixed by glue, once a glue cast is formed therein the band can be removed. An implant 10' will then include a proximal hub 30' that is reduced in diameter (by as much as about 0.004 inches depending on band thickness) and is also less noticeable by offering less contrast. Outside the body (e.g., in packaging) a physician will see a glaze or sheen of adhesive/glue 70 as a cast 72 in which the braid is embedded instead of a high contrast marker 32.
[0036] While seemingly unimportant to function, this visual aspect can indeed be
relevant. The impression of physicians regarding the bulk of the proximal feature can affect whether the physician adopts the product. Conventional implants have been designed with the proximal hub completely inset within the inner volume of the implant. This is done to make the implant's appearance more attractive to physicians. However, the implant suffers in performance as a result (e.g., the implant is more difficult to recapture; the requirements on the implant's wire size and strength are heightened to force the implant to recover the inset shape, leading to an undesirable increase in implant dimension; and other performance deficiencies). In the present aspect of the invention, the perceived hub size is reduced, which increases the visual appeal without compromising performance.
[0037] Figs. 10A and 10B illustrate additional embodiments that eliminate the outer band while providing relatively increased radiopacity. Specifically, minimal implant hub size can be achieved by relocating a radiopaque band feature to an in-line arrangement with the inner band 34. A simple Pt band 74 can be set atop the inner band 34 as shown in Fig. 10A. These members may be joined using conventional techniques (i.e., gluing, soldering, welding, etc.) or be held in relation to one another on a temporary basis by utilizing delivery system interface members as shown in Fig. 18, etc. to the embodiment of Fig. 10B interlocks members 34 and 74 through the use of lock 76 and key 78 features.
[0038] Another implant feature is illustrated in connection with Figs. 1 1 and 12. The implant optionally includes a flattened top 80 adjacent distal aperture 18. The flattened top is generated by providing a table surface 82 in the molding element 88 used to define the bulk shape of the implant. Molding elements, or "forms," in different sizes 88, 88' and 88" are shown in Fig. 12. They are milled down from a spherical form to define flat 82 surrounded by edge 84. The edge produces a crease 86 in the braid wire. Note that flat 80 and crease 86 are shown in alternate views in Figs. 2A and 2B.
[0039] During implant preform heatsetting, it has been found that the flat section
improves the quality of the distal fold 16 in the implant, helping to maximize uniformity and minimize the bend radius in the wires. As such, device trackability through tortuous anatomy within a catheter is also improved. The crease at the edge of the flattened area set in the implant also helps with delivery performance upon deployment. Specifically, as illustrated in Fig. 13A, the crease 86 represents multiple bends in the wires forming the implant braid matrix. Upon exit from the microcatheter, the bends recover and cause the implant distal end to open more than an implant without such a crease as shown in Fig. 13B (see also, the implant in Fig. I B). As a more open body, the implant is softer, with more relaxed braid angle should it contact any fragile tissue - such as the dome of an aneurysm.
[0040] Other architectural changes or augmentations that may be applied to implants are shown in Figs. 14-17. Each approach offers the potential for diagrammatically improved density relative to the parent architecture illustrated in Fig. 4. [0041] Specifically, implant 90 includes an intermediate braid layer 92 set between outer layer 12 and inner layer 14. Layer 92 is captured in hub 30 as are the other layers at a proximal attachment 94. The distal extent 96 can be set at a number of positions. Advantageously, it extends to around the half-way point or equator of the device. This way, the layer will contribute to implant density (or - stated otherwise - reduce porosity) even for wide-neck aneurysms.
[0042] As shown in Fig. 14, the distal extent 96 of the braid is adjacent to the folded- over section 16 of the implant. Here, the density is highest so the inner layer wires will tend to stay best trapped between layers 12 and 14. Yet, since the ends 96 do not interfere with the fold 16 (which can be the highest profile aspect of the implant) little or no increase in crossing profile need result.
[0043] In production, the inner layer 92 of the implant can be produced simply by cutting a preform (like preform 62) in half at the distal fold. This produces a set of two inner layer sections that can be used in two different devices from a single formation procedure. However produced, because the inner layer may rely on the other layers for structural definition, it may be made of finer wire and/or with lower braid count than the other layers. For instance, the inner layer may comprise 72-end 0.0008 inch wire braid, whereas the outer layers comprise 96-end 0.0008 inch wire braid. However, the reverse may be true, in which the inner layer is more robust. In any case, it may be advantageous to mismatch the number of wire ends included in the braid (such as in the example directly above) to help avoid wire match-up, thereby minimizing porosity.
[0044] Implant 100 shown in Fig. 15 illustrates another advantageous approach to
improving flow disruption effect, without increasing device crossing profile. As in device 90, an intermediate braid layer 90 is employed. However its proximal end is not secured within the hub, thereby easing space constraints in that region.
[0045] Instead, braid matrix integrity is maintained by coating the braid layer with a polymer (e.g., TICOPHILIC coating by Lubrizol, Inc.) or other coatings or processing. Hydrogel coating also offers an appealing option, such as a hydrogel-based polymer network capable of entrapping therapeutic agents as described in USPN 6,905,700 to Won et al. Likewise, while the implant elements advantageously comprise Nitinol braid (ty pically superelastic NiTi). the braid used for any of the layers may instead comprise polymer - especially high strength biodegradable polymer such as MX-2 (MAX-Prene), synthetic absorbable monofilament (90/ 10 Glycolide/L-Lactide) and/or G-2 (Glycoprene), synthetic absorbable monofilament (Glycolide (PGA), ε- Caprolactone (PCL), Trimethylene Carbonate (TMC) Copolymer) that is heat set into shape (e.g., at 1 10 degrees centigrade for an hour) and/or coated with the same to stabilize the braid matrix as described.
[0046] Implant 1 10 shown in Fig. 16 offers another yet another approach for improved embolizing (or flow disrupting) effect with little or no effect on crossing profile. Such effect is accomplished by affixing an innermost/third braid layer 1 12 to inner band 34 at its proximal end 1 14. It may be welded, glued, soldered or otherwise affixed thereto. The distal end of the braid 1 16 may be trimmed and formed as shown or otherwise. For example, the cup so-formed may closely follow the inner periphery of the device up to or past its equator.
[0047] As with variations in the previous figures, the third layer incorporated in the implant simply deploys and recaptures in unison with the rest of the implant. Unique, however, to the architecture of Fig. 1 6 is that the proximal end 1 14 of the braid is stably secured, but secured such that it does not require space in the hub (e.g., within the outer marker band 32) without dimensional stackup.
[0048] A related implant configuration is shown in Fig. 17. Here, in implant 120, the same proximal end 1 14 attachment approach is employed. Yet, instead of forming (e.g., by heatsetting) the inner layer of braid into a cup shape, an inner ball 1 18 is formed. The proximal side of the ball improves overall proximal-side implant density, and also defines separated flow stagnation zones A and B within the implant to further assist in thrombus formation within the implant.
[0049] Inner ball body 1 18 may be shape set over a form. Alternatively, and more advantageously, the shape can be formed without either an external or internal form by bunching the braid up and tying it onto a mandrel for heatsetting. Such a "free- forming" approach is functionally advantageous because it maximizes braid angle (hence, density) in the final body. Yet, any resulting inconsistency in shape is manageable given that the only outer body of the implant defined by braid layers 12 and 14 is in contact with an aneurysm.
[0050] Irrespective of how it is formed (and the particular braid configuration
selection) the inner ball 118 within the architecture will be configured so that it will not interfere with the distal end of the implant body/shell and/or marker and tether when the device is compressed for delivery or recapture.
[0051] More generally, Fig. 18 provides an overview of implant-side of a treatment system 200. The system includes an implant 10 (90, 100, 1 10, 120) and a
pusher/catheter shaft 210 ultimately attached to a handle 220 (e.g., as shown in Figs. 19A- 19-E). Any of these may be constructed according to the teachings herein and/or incorporated by reference.
[0052J One handle construction includes a single plunger. The plunger pulls a collar that progressively engages and pulls sockets connected to the wires; first each control wire 212 is pulled (one at a time), then the anchor wire 214. Such action is illustrated in Figs. 19A- 19E and 20A-20E. Figs. 19A and 20A show the device components as removed from packaging. Fig. 19B illustrates unlocking the handle plunger 222 with a 120 degree rotation relative to handle body 224. Such action has no effect on the detachment interface 216 shown in Fig. 20B. However, progressive pull of the plunger in Figs. 19C-19E effect the release of the system as shown in Figs. 20C-20E.
[0053] Fig. 21 shows an optional improvement to the architecture of system 200. Here, system 200' has only one "true" control wire 212 is received within the hub or inner band 30/34 of the implant 10. Even so, the implant remains securely/stably attached to the catheter shaft by virtue of the control wire interaction with anchor ball 216 (e.g., as formed by laser or as otherwise configured).
[0054] Release of the implant is effected as if progressing from the steps in Figs. 19C and 20C to 19E and 20E. However, a third (floating or actuated) "dummy" wire 218 is still loaded within the lumen of pusher shaft 210. Use of this wire maintains a close- packed arrangement of the wires inside shaft 210, which can be important in determining wire position within a tortuous setting. Yet, release angle may be increased and plunger pull force reduced because the wires within the implant have more space between them allowing for spatial accommodation.
[0055] Note that the length "L" by which wire 218 is inset within the pusher shaft may vary depending on purpose. It may have no inset (i.e., essentially abut the implant proximal end). It may be inset by about 1 mm so that any forward motion in a tortuous setting does not result in contact with the implant. Or it may be inset to a greater degree (e.g., between about 1 cm and 5 cm) to improve distal tip flexibility of delivery pusher shaft 210.
[0056] Figs. 22A and 22B show an alternative delivery system interface in engaged and disengaged states, respectively. Here, system 230 comprises a catheter/pusher shaft 232 actuated with the assistance of a typical torque 234. Torquer 234 locks a position of a central wire 236 including an anchor ball for implant 10 delivery. A bumper or shoulder 240 may be affixed to the catheter (optionally a Pt band also serving as a marker) to abut a hub 30 of the implant for pushing. [0057J Engagement is achieved between the implant and pusher shaft by virtue of extension 242 that is offset into an interfering relationship with an inner band 34 of the implant when the anchor ball 238 is in a retracted position as shown in Fig. 22A. When wire 236 (and its terminal ball feature 238) is advanced as shown in Fig. 22B, extension section 242 is free to move (e.g., to return to its original position by elastic action or upon catheter shaft withdrawal) and slide out of the implant.
[0058] Fig. 23 is an end-on view of the delivery system interface as pictured in Fig.
22B. As shown, no interference between the ball 238 and/or extension persists once wire 236 is advanced. Fig. 24A portrays a similar view without the wire in place. It shows extension 242 and catheter body 232. And while they are illustrated as formed in one manner (i.e., with a 90 degree cut-down), it is to be appreciated that the extension may instead be formed by an angular cut or otherwise. Indeed, Fig. 24B shows an approach in which the extension section is formed by pushing over the catheter wall on one side to meet the other and optionally heat setting, fusing or gluing the component parts 242 and 242' together.
[0059] Figs 25A and 25B show an alternative delivery system interface 250 option
(engaged and disengaged, respectively) based on the pusher shaft extension configuration in Fig. 24B. Due to the increased wall thickness offered by the double wall layer, the system can work much as that shown in Figs. 22A and 22B, except without need for a distal interference feature (i.e., anchor ball/band). As such, withdrawal of wire 236 will relieve the interference and unlock the pusher shaft 232 (specifically, the associated extension) for withdrawal from the implant 10.
[0060] Fig. 26 shows an alternative implant-side interface with a delivery system as presented in Figs. 25A and 25B. Here an implant socket 260 is provided. Socket 260 may be defined by a cup 262 attached to one or more implant braid layers (12/14), by welding or otherwise, and a reducer tube 264 threaded, pressed or otherwise affixed in the proximal end of the cup. Note that with such an arrangement that implant pushing can be accomplished without a shoulder or other proximal interface. Instead, both push and pull (for withdrawal) force application can occur within the socket chamber. While such a socket will typically be larger than the previous interfaces shown, it is easily retrofit or used as and alternative to the screw-type release approaches employed in many vessel sacrifice and closure devices as sold by AGA Medical, Inc. and others.
[0061] The delivery system configuration in Fig. 27 shows the same implant-side
interface 260, with an alternative pusher-side engagement/disengagement (or latch) architecture 270. This architecture is a simplified version of that shown in Fig. 1 8 of Becking et al. Specifically, a pusher shaft 272 (e.g., metal hypotube) is provided with a single window cutout 274. The window (configured as a square cutout, rounded, or a simple kerf) allowing a core member 276 (e.g.. NiTi ribbon) to pass therethrough and provide interference against pusher shaft distal face 276 to prevent delivery system detachment until core member withdrawal.
[0062] Figs. 28A and 28B show an alternative latch interface 280 for a system like that shown in Figs. 22A and 22B. In this system, a bent back wire hook 282 serves the function of the ball in the former system. Such a system offers the advantage of very low cost production, as well as a secure anchoring feature. Fig. 29 shows a system 290 most closely related to that in Fig. 21 , except that multiple control and/or dummy wires are replaced with a single ribbon 292.
[0063] Finally, Fig. 30 shows a detachment system 300. As in system 290 a ribbon 292 may be used in conjunction with a round anchor wire 214 with a ball-shaped anchor 216. An alternative approach that may be used in either system is to employ a ribbon as the "anchor wire" and form the interference feature at its end by tying a knot therein (as a substitute for a laser-formed ball). Such a knot can be shape set, glued or welded to stabilize its shape. It can be reliably be produced at low cost at a very small size, on a ribbon. A socket-type interface can be formed within the coil by fitting a collar feature 302 within its proximal end. The collar may be threaded-in (i.e., into the coils like a thread pitch). An alternative approach involves flowing solder between the coils and defining a lumen therein using a removable mandrel. The mandrel may be prepared in any manner to facilitate its removal, including those described for the removable hub in connection with the improvement described in connection with Fig. 9B.
[0064] In the various delivery system architectures, the catheter/pusher shaft comprise a simple extrusion (e.g., PTFE, FEP, PEEK, etc.) or may be constructed using conventional catheter construction techniques and include a liner, braid support and outer jacket (not shown). An exemplary construction is available through
MicroLumen, Inc. as Braid Reinforced Polyimide. A distal section of the Polyimide may be ablated and replaced with fused Pebax to provide a softer or progressively- flexible end to the catheter. A loading sheath is typically provided over the pusher shaft. Advantageously, the loading sheath is splittable.
[0065] If not preloaded, after removal from sterile packaging (not shown), the implant is pulled into the loading sheath. The loading sheath is received within the hub of the catheter to be used for implant delivery and the implant is advanced into the catheter. Then, the implant may be advanced to and deployed at a treatment site. Or it may be retrieved in exchange for another size implant - else repositioned, if desired, prior to ultimate detachment as illustrated in the incorporated patent application subject matter.
[0066] In the present invention, the subject methods may include each of the physician activities associated with implant positioning and release. As such, methodology implicit to the positioning and deployment of an implant device forms part of the invention. Such methodology may include placing an implant within a brain aneurysm, or at parent vessel targeted for occlusion, or other applications. In some methods, the various acts of implant introduction to an aneurysm or parent vessel are considered.
[0067] More particularly, a number of methods according to the present invention involve the manner in which the delivery system operates in reaching a treatment site, for example. Other methods concern the manner in which the system is prepared for delivering an implant, for example attaching the braid ball to the delivery system. Any method herein may be carried out in any order of the recited events which is logically possible, as well as in the recited order of events, or slight modifications of those events or the event order.
[0068] It is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Reference to a singular item, includes the possibility that there is a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms "a," "an," "said," and "the" include plural referents unless specifically stated otherwise. In other words, use of the articles allow for "at least one" of the subject item in the description above as well as the claims below. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as "solely," "only" and the like in connection with the recitation of claim elements, or use of a "negative" limitation.
[0069] Without the use of such exclusive terminology , the term "comprising" in the claims shall allow for the inclusion of any additional element irrespective of whether a given number of elements are enumerated in the claim, or the addition of a feature could be regarded as transforming the nature of an element set forth in the claims.
Except as specifically defined herein, all technical and scientific terms used herein are to be given as broad a commonly understood meaning as possible while maintaining claim validity.
[0070] The breadth of the present invention is not to be limited to the examples
provided and/or the subject specification, but rather only by the scope of the claim language. Use of the term "invention" herein is not intended to limit the scope of the claims in any manner. Rather it should be recognized that the "invention" includes the many variations explicitly or implicitly described herein, including those variations that would be obvious to one of ordinary skill in the art upon reading the present specification. Further, it is not intended that any section of this specification (e.g., the Summary, Detailed Description, Abstract, Field of the Invention, etc.) be accorded special significance in describing the invention relative to another or the claims. All references cited are incorporated by reference in their entirety. Although the foregoing invention has been described in detail for purposes of clarity of understanding, it is contemplated that certain modifications may be practiced within the scope of the appended claims.

Claims

CLAIM S What is claimed is:
1 . An embol ic device comprising a body having proximal and d istal sides, with a radiopaque marker positioned within the body and held adjacent the distal side by at least one filament, the improvement comprising:
the at least one fi lament extending from the marker to the proximal side, and having a length to cause the marker to align with the body when the body is in a compressed configuration.
2. The embolic device of claim 1 , wherein the at least one fi lament comprises suture material, and the suture material is knotted to secure a proximal side of the marker.
3. The embolic device of claim 1 , wherein the at least one fi lament comprises a metal ribbon of material weldable to the body for securement at the proximal side of the body.
4. An embol ic device comprising a multi-fi lament body having proximal and distal sides, the improvement comprising:
a flat formed across the distal side of the body, providing a circular crease in the filaments.
5. An embolic device comprising braid form ing inner and outer layers of the device, the layers defining an open volume and being adapted to compress for delivery through a catheter and expand when unconstrained, the inner and outer layers meeting at a folded section closed at one end of the device and at a hub closing and holding at least the outer braid layer at the other end of the device, the improvement comprising:
an intermediate layer of braid positioned between the inner and outer layers.
6. The device of claim 5, wherein the intermediate layer is not attached at either a proximal side or a distal side of the device, and the intermediate layer is positioned between the compressed and expanded states.
7. The device of claim 5, wherein a proximal side of the intermediate layer is incorporated into the hub of the device.
8. The device of claim 7, where a d istal side of the intermediate layer is positioned adjacent the folded section.
9. An embolic device comprising braid form ing inner and outer layers of the device, the layers defining an open volume and being adapted to compress for delivery through a catheter and expand when unconstrained, the inner and outer layers meeting at a folded section, closed at one end of the device, and at a hub, closing and holding at least the outer braid layer at the other end of the device, the improvement comprising:
an elongate band within the hub and an additional braid layer connected to the band distal to the hub.
10. The device of claim 9, wherein the additional layer is cup-shaped when the device is expanded.
1 1. The device of claim 9, wherein the additional layer is ball-shaped when the device is expanded.
12. An detachable implant pusher system comprising an implant including a proximal port section, an elongate pusher sleeve, a plurality of elongate members received within a lumen of the sleeve, wherein the sleeve is locked to the implant through interference with a distal surface of the port section until the at least one of the plurality of elongate members is drawn into the sleeve, the improvement comprising: not all of the plurality of elongate members exiting at proximal and distal ends of the pusher sleeve and received through the implant port.
13. An detachable implant pusher system comprising:
an implant including a proximal port section;
an elongate pusher sleeve;
an elongate member received within a lumen of the sleeve, exiting at proximal and distal ends of the sleeve;
the elongate member and the distal end of the sleeve received through the implant port section,
wherein the sleeve is adapted to lock to the implant, through interference with a distal surface of the port section, until the elongate member is displaced.
14. An detachable implant pusher system comprising an implant including a proximal port section, an elongate pusher sleeve, at least one elongate member received within a lumen of the sleeve, exiting at proximal and distal ends and received through the implant port, wherein the sleeve is adapted to lock to the implant, through interference with a distal surface of the port section, until the at least one elongate member is drawn into the sleeve, the improvement comprising:
the proximal port configured as a socket.
15. An embolic device comprising braid forming inner and outer layers of the device, the layers defining an open volume and being adapted to compress for delivery through a catheter and expand upon release from constraint, the inner and outer layers meeting at a folded section closed at one end of the device and at a hub closing and holding at least the outer braid layer at the other end of the device, the improvement comprising:
an elongate band welded within the hub and another adjacent band aligned therewith the adjacent band comprising a material that is relatively more radiopaque than the elongate band.
16. A method of making an embolic device, the method comprising: forming a body of the implant over a hypotube;
affixing the braid to the hypotube; and
trimming the hypotube, leaving a band within the implant.
1 7. A method of making an embol ic device, the method comprising: forming a multi-filament body of the device;
setting a band for a hub region of the device;
applying adhesive to secure filament ends within the hub region; and removing the band from the hub region with the filaments secured in the hub region.
EP10785550.4A2009-11-092010-11-09Braid ball embolic device featuresActiveEP2498691B1 (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US25958509P2009-11-092009-11-09
PCT/US2010/056051WO2011057277A2 (en)2009-11-092010-11-09Braid ball embolic device features

Publications (2)

Publication NumberPublication Date
EP2498691A2true EP2498691A2 (en)2012-09-19
EP2498691B1 EP2498691B1 (en)2015-01-07

Family

ID=43558291

Family Applications (1)

Application NumberTitlePriority DateFiling Date
EP10785550.4AActiveEP2498691B1 (en)2009-11-092010-11-09Braid ball embolic device features

Country Status (8)

CountryLink
US (2)US9095342B2 (en)
EP (1)EP2498691B1 (en)
JP (1)JP5711251B2 (en)
CN (1)CN102791205B (en)
AU (1)AU2010314871B2 (en)
CA (1)CA2779483C (en)
ES (1)ES2534192T3 (en)
WO (1)WO2011057277A2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP3865079A1 (en)*2020-02-142021-08-18DePuy Synthes Products, Inc.Intravascular implant deployment system
US11147562B2 (en)2018-12-122021-10-19DePuy Synthes Products, Inc.Systems and methods for embolic implant detachment
US11207494B2 (en)2019-07-032021-12-28DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant distal portion
US11253265B2 (en)2019-06-182022-02-22DePuy Synthes Products, Inc.Pull wire detachment for intravascular devices
US11376013B2 (en)2019-11-182022-07-05DePuy Synthes Products, Inc.Implant delivery system with braid cup formation
US11426174B2 (en)2019-10-032022-08-30DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant mechanical release
US11457922B2 (en)2020-01-222022-10-04DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant distal portion
US11826051B2 (en)2017-12-212023-11-28DePuy Synthes Products, Inc.Implantable medical device detachment system with split tube and cylindrical coupling
US11871931B2 (en)2014-08-082024-01-16DePuy Synthes Products, Inc.Embolic coil delivery system with retractable mechanical release mechanism
US11937824B2 (en)2021-12-302024-03-26DePuy Synthes Products, Inc.Implant detachment systems with a modified pull wire
US11937825B2 (en)2022-03-022024-03-26DePuy Synthes Products, Inc.Hook wire for preventing premature embolic implant detachment
US11937826B2 (en)2022-03-142024-03-26DePuy Synthes Products, Inc.Proximal link wire for preventing premature implant detachment
US11951026B2 (en)2020-06-302024-04-09DePuy Synthes Products, Inc.Implantable medical device detachment system with flexible braid section
US12011171B2 (en)2022-01-062024-06-18DePuy Synthes Products, Inc.Systems and methods for inhibiting premature embolic implant deployment
US12137915B2 (en)2022-03-032024-11-12DePuy Synthes Products, Inc.Elongating wires for inhibiting premature implant detachment
US12402886B2 (en)2022-06-232025-09-02DePuy Synthes Products, Inc.Detachment indicator for implant deployment

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060155323A1 (en)*2005-01-072006-07-13Porter Stephen CIntra-aneurysm devices
US8777979B2 (en)2006-04-172014-07-15Covidien LpSystem and method for mechanically positioning intravascular implants
JP5230602B2 (en)2006-04-172013-07-10タイコ ヘルスケア グループ リミテッド パートナーシップ System and method for mechanically positioning an endovascular implant
US20110022149A1 (en)2007-06-042011-01-27Cox Brian JMethods and devices for treatment of vascular defects
EP2633823B1 (en)2008-04-212016-06-01Covidien LPBraid-ball embolic devices and delivery systems
US10716573B2 (en)2008-05-012020-07-21AneucloseJanjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en)2008-05-012018-07-24Aneuclose LlcCoils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
AU2009242528B2 (en)*2008-05-022015-12-10Microvention, Inc.Filamentary devices for treatment of vascular defects
WO2009140437A1 (en)2008-05-132009-11-19Nfocus Neuromedical, Inc.Braid implant delivery systems
US9402707B2 (en)2008-07-222016-08-02Neuravi LimitedClot capture systems and associated methods
US9179918B2 (en)2008-07-222015-11-10Covidien LpVascular remodeling device
BR112012010758A2 (en)2009-11-052019-09-24Sequent Medical Inc multilayer filament devices for treatment of vascular defects
US9814562B2 (en)2009-11-092017-11-14Covidien LpInterference-relief type delivery detachment systems
US9095342B2 (en)2009-11-092015-08-04Covidien LpBraid ball embolic device features
US9358140B1 (en)2009-11-182016-06-07Aneuclose LlcStent with outer member to embolize an aneurysm
WO2011094638A1 (en)2010-01-282011-08-04Micro Therapeutics, Inc.Vascular remodeling device
WO2011094634A1 (en)2010-01-282011-08-04Micro Therapeutics, Inc.Vascular remodeling device
US8998947B2 (en)2010-09-102015-04-07Medina Medical, Inc.Devices and methods for the treatment of vascular defects
CA2812012C (en)2010-09-102018-01-02Medina Medical, Inc.Devices and methods for the treatment of vascular defects
ES2683943T3 (en)2010-10-222018-09-28Neuravi Limited Clot capture and removal system
JP5868432B2 (en)2011-02-112016-02-24コヴィディエン リミテッド パートナーシップ Two-stage deployed aneurysm embolization device
US11259824B2 (en)2011-03-092022-03-01Neuravi LimitedClot retrieval device for removing occlusive clot from a blood vessel
US12076037B2 (en)2011-03-092024-09-03Neuravi LimitedSystems and methods to restore perfusion to a vessel
EP4566553A3 (en)2011-03-092025-08-06Neuravi LimitedA clot retrieval device for removing occlusive clot from a blood vessel
US20120245674A1 (en)2011-03-252012-09-27Tyco Healthcare Group LpVascular remodeling device
US20120330341A1 (en)*2011-06-222012-12-27Becking Frank PFolded-Flat Aneurysm Embolization Devices
US9060886B2 (en)2011-09-292015-06-23Covidien LpVascular remodeling device
US8945171B2 (en)2011-09-292015-02-03Covidien LpDelivery system for implantable devices
US8795313B2 (en)2011-09-292014-08-05Covidien LpDevice detachment systems with indicators
US9579104B2 (en)2011-11-302017-02-28Covidien LpPositioning and detaching implants
EP3266488B1 (en)*2012-01-312019-02-27Boston Scientific Scimed, Inc.Guide extension catheter
US9314248B2 (en)2012-11-062016-04-19Covidien LpMulti-pivot thrombectomy device
US10327781B2 (en)2012-11-132019-06-25Covidien LpOcclusive devices
US9295571B2 (en)2013-01-172016-03-29Covidien LpMethods and apparatus for luminal stenting
CN103110444A (en)*2013-01-222013-05-22陈平根Biodegradable fabric body capable of being developed and conveying device
US9119948B2 (en)2013-02-202015-09-01Covidien LpOcclusive implants for hollow anatomical structures, delivery systems, and related methods
US9662119B2 (en)*2013-03-132017-05-30Lawrence Livermore National Security, LlcShape-memory polymer foam device for treating aneurysms
WO2014140092A2 (en)2013-03-142014-09-18Neuravi LimitedDevices and methods for removal of acute blockages from blood vessels
ES2708786T3 (en)2013-03-142019-04-11Neuravi Ltd Clot recovery device to remove occlusive clots from a blood vessel
US9463105B2 (en)2013-03-142016-10-11Covidien LpMethods and apparatus for luminal stenting
US9433429B2 (en)2013-03-142016-09-06Neuravi LimitedClot retrieval devices
CN105142544A (en)*2013-03-152015-12-09柯惠有限合伙公司 Interference-Relief Type Conveyor Separation System
US10736758B2 (en)2013-03-152020-08-11CovidienOcclusive device
CN110169802B (en)*2013-03-152022-07-08柯惠有限合伙公司Delivery and detachment mechanism for vascular implants
US11291452B2 (en)*2013-06-262022-04-05W. L. Gore & Associates, Inc.Medical device deployment system
US9955976B2 (en)2013-08-162018-05-01Sequent Medical, Inc.Filamentary devices for treatment of vascular defects
US9078658B2 (en)2013-08-162015-07-14Sequent Medical, Inc.Filamentary devices for treatment of vascular defects
US11076860B2 (en)2014-03-312021-08-03DePuy Synthes Products, Inc.Aneurysm occlusion device
US11154302B2 (en)*2014-03-312021-10-26DePuy Synthes Products, Inc.Aneurysm occlusion device
US9629635B2 (en)2014-04-142017-04-25Sequent Medical, Inc.Devices for therapeutic vascular procedures
US10130372B2 (en)2014-04-302018-11-20Cerus Endovascular LimitedOcclusion Device
US10617435B2 (en)2014-11-262020-04-14Neuravi LimitedClot retrieval device for removing clot from a blood vessel
US11253278B2 (en)2014-11-262022-02-22Neuravi LimitedClot retrieval system for removing occlusive clot from a blood vessel
EP3682821B1 (en)2014-11-262022-05-11Neuravi LimitedA clot retrieval device for removing an occlusive clot from a blood vessel
CA2976260C (en)2015-02-252024-02-06Galaxy Therapeutics, LlcSystem for and method of treating aneurysms
US9375333B1 (en)2015-03-062016-06-28Covidien LpImplantable device detachment systems and associated devices and methods
US10478194B2 (en)2015-09-232019-11-19Covidien LpOcclusive devices
US10314593B2 (en)2015-09-232019-06-11Covidien LpOcclusive devices
EP4011303B1 (en)2015-12-072024-06-12Cerus Endovascular LimitedOcclusion device
AU2017218115B2 (en)2016-02-102020-03-05Microvention, Inc.Devices for vascular occlusion
WO2017153603A1 (en)*2016-03-112017-09-14Cerus Endovascular LimitedOcclusion device
EP3463109A4 (en)2016-05-262020-01-08Nanostructures, Inc.System and methods for embolized occlusion of neurovascular aneurysms
US11191611B2 (en)2016-06-032021-12-07Somatex Medical Technologies GmbhMarking device and implantation system
US10470773B2 (en)2016-06-102019-11-12Terumo CorporationVessel occluder
US10478195B2 (en)2016-08-042019-11-19Covidien LpDevices, systems, and methods for the treatment of vascular defects
US20180056043A1 (en)*2016-08-292018-03-01Randolf Von OepenAdjustable guidewire receiving member
EP3509509B1 (en)2016-09-062021-03-31Neuravi LimitedA clot retrieval device for removing occlusive clot from a blood vessel
WO2018075700A1 (en)2016-10-182018-04-26Boston Scientific Scimed, Inc.Guide extension catheter
US10576099B2 (en)2016-10-212020-03-03Covidien LpInjectable scaffold for treatment of intracranial aneurysms and related technology
WO2018097891A1 (en)2016-11-232018-05-31Hologic, Inc.Biopsy site marker
CN110545739A (en)2017-02-232019-12-06德普伊新特斯产品公司aneurysm devices and delivery systems
US11191927B2 (en)2017-07-312021-12-07Boston Scientific Scimed, Inc.Dilator with engagement region
US11000287B2 (en)2017-08-152021-05-11Boston Scientific Scimed, Inc.Occlusive medical device system
JP7414710B2 (en)2017-08-212024-01-16シーラス エンドバスキュラー リミテッド occlusion device
US10675036B2 (en)2017-08-222020-06-09Covidien LpDevices, systems, and methods for the treatment of vascular defects
US10874402B2 (en)2017-10-102020-12-29Boston Scientific Scimed, Inc.Detachable RF energized occlusive device
US11058444B2 (en)2017-12-112021-07-13Covidien LpElectrically enhanced retrieval of material from vessel lumens
US11974752B2 (en)2019-12-122024-05-07Covidien LpElectrically enhanced retrieval of material from vessel lumens
US12318126B2 (en)2021-06-252025-06-03Covidien LpCurrent generator for a medical treatment system
US10874411B2 (en)2018-06-222020-12-29Covidien LpElectrically enhanced retrieval of material from vessel lumens
US11185335B2 (en)2018-01-192021-11-30Galaxy Therapeutics Inc.System for and method of treating aneurysms
US10905430B2 (en)2018-01-242021-02-02DePuy Synthes Products, Inc.Aneurysm device and delivery system
CN111936063B (en)2018-01-312024-08-20纳米结构公司Vascular occlusion device utilizing thin film nitinol foil
WO2019152775A1 (en)2018-02-012019-08-08Boston Scientific Scimed, Inc.Medical device release system
US11284902B2 (en)2018-02-012022-03-29Boston Scientific Scimed, Inc.Method of making a vascular occlusion device
JP2021520255A (en)2018-04-042021-08-19インキュメデックス インコーポレイテッド Embolic device with improved reduced diameter coating
US11596412B2 (en)2018-05-252023-03-07DePuy Synthes Products, Inc.Aneurysm device and delivery system
US11058430B2 (en)2018-05-252021-07-13DePuy Synthes Products, Inc.Aneurysm device and delivery system
US10939915B2 (en)2018-05-312021-03-09DePuy Synthes Products, Inc.Aneurysm device and delivery system
US11051825B2 (en)2018-08-082021-07-06DePuy Synthes Products, Inc.Delivery system for embolic braid
US10842498B2 (en)2018-09-132020-11-24Neuravi LimitedSystems and methods of restoring perfusion to a vessel
WO2020060932A1 (en)2018-09-182020-03-26Nanostructures, Inc.Catheter based methods and devices for obstructive blood flow restriction
US11123077B2 (en)2018-09-252021-09-21DePuy Synthes Products, Inc.Intrasaccular device positioning and deployment system
US11406416B2 (en)2018-10-022022-08-09Neuravi LimitedJoint assembly for vasculature obstruction capture device
US11076861B2 (en)2018-10-122021-08-03DePuy Synthes Products, Inc.Folded aneurysm treatment device and delivery method
US11406392B2 (en)2018-12-122022-08-09DePuy Synthes Products, Inc.Aneurysm occluding device for use with coagulating agents
US11730485B2 (en)2018-12-172023-08-22Covidien LpDevices, systems, and methods for the treatment of vascular defects
US11272939B2 (en)2018-12-182022-03-15DePuy Synthes Products, Inc.Intrasaccular flow diverter for treating cerebral aneurysms
US11134953B2 (en)2019-02-062021-10-05DePuy Synthes Products, Inc.Adhesive cover occluding device for aneurysm treatment
CN113573765B (en)2019-03-152024-08-13美科微先股份有限公司Silk device for treating vascular defects
US11559309B2 (en)2019-03-152023-01-24Sequent Medical, Inc.Filamentary devices for treatment of vascular defects
CN113573650B (en)2019-03-152024-05-28后续医疗股份有限公司 Silk device with flexible connector for treating vascular defects
US11612430B2 (en)2019-03-192023-03-28Covidien LpElectrically enhanced retrieval of material from vessel lumens
US11337706B2 (en)2019-03-272022-05-24DePuy Synthes Products, Inc.Aneurysm treatment device
US11278292B2 (en)2019-05-212022-03-22DePuy Synthes Products, Inc.Inverting braided aneurysm treatment system and method
US11607226B2 (en)2019-05-212023-03-21DePuy Synthes Products, Inc.Layered braided aneurysm treatment device with corrugations
US11497504B2 (en)2019-05-212022-11-15DePuy Synthes Products, Inc.Aneurysm treatment with pushable implanted braid
US11413046B2 (en)2019-05-212022-08-16DePuy Synthes Products, Inc.Layered braided aneurysm treatment device
US10653425B1 (en)2019-05-212020-05-19DePuy Synthes Products, Inc.Layered braided aneurysm treatment device
US11602350B2 (en)2019-12-052023-03-14DePuy Synthes Products, Inc.Intrasaccular inverting braid with highly flexible fill material
US11672542B2 (en)2019-05-212023-06-13DePuy Synthes Products, Inc.Aneurysm treatment with pushable ball segment
US11202636B2 (en)2019-05-252021-12-21Galaxy Therapeutics Inc.Systems and methods for treating aneurysms
US12102327B2 (en)2019-05-252024-10-01Galaxy Therapeutics, Inc.Systems and methods for treating aneurysms
US11523838B2 (en)*2019-06-122022-12-13Covidien LpRetrieval of material from corporeal lumens
US11191558B2 (en)2019-06-122021-12-07Covidien LpRetrieval of material from corporeal lumens
US11672946B2 (en)2019-09-242023-06-13Boston Scientific Scimed, Inc.Protection and actuation mechanism for controlled release of implantable embolic devices
US11712231B2 (en)2019-10-292023-08-01Neuravi LimitedProximal locking assembly design for dual stent mechanical thrombectomy device
WO2021092618A1 (en)2019-11-042021-05-14Covidien LpDevices, systems, and methods for treatment of intracranial aneurysms
US11517340B2 (en)2019-12-032022-12-06Neuravi LimitedStentriever devices for removing an occlusive clot from a vessel and methods thereof
US11395668B2 (en)2019-12-122022-07-26Covidien LpElectrically enhanced retrieval of material from vessel lumens
US11457926B2 (en)2019-12-182022-10-04DePuy Synthes Products, Inc.Implant having an intrasaccular section and intravascular section
US11406404B2 (en)2020-02-202022-08-09Cerus Endovascular LimitedClot removal distal protection methods
US20210282789A1 (en)2020-03-112021-09-16Microvention, Inc.Multiple layer devices for treatment of vascular defects
US12070220B2 (en)2020-03-112024-08-27Microvention, Inc.Devices having multiple permeable shells for treatment of vascular defects
US12023034B2 (en)2020-03-112024-07-02Microvention, Inc.Devices for treatment of vascular defects
US11717308B2 (en)2020-04-172023-08-08Neuravi LimitedClot retrieval device for removing heterogeneous clots from a blood vessel
US11730501B2 (en)2020-04-172023-08-22Neuravi LimitedFloating clot retrieval device for removing clots from a blood vessel
US11871946B2 (en)2020-04-172024-01-16Neuravi LimitedClot retrieval device for removing clot from a blood vessel
US11931041B2 (en)2020-05-122024-03-19Covidien LpDevices, systems, and methods for the treatment of vascular defects
EP4153065A1 (en)*2020-05-192023-03-29Boston Scientific LimitedMedical delivery systems and methods of using the same
US11737771B2 (en)2020-06-182023-08-29Neuravi LimitedDual channel thrombectomy device
US11937836B2 (en)2020-06-222024-03-26Neuravi LimitedClot retrieval system with expandable clot engaging framework
US11395669B2 (en)2020-06-232022-07-26Neuravi LimitedClot retrieval device with flexible collapsible frame
US11439418B2 (en)2020-06-232022-09-13Neuravi LimitedClot retrieval device for removing clot from a blood vessel
US11864781B2 (en)2020-09-232024-01-09Neuravi LimitedRotating frame thrombectomy device
US12383246B2 (en)2020-10-122025-08-12Abbott Cardiovascular Systems, Inc.Vessel closure device with improved safety and tract hemostasis
US11937837B2 (en)2020-12-292024-03-26Neuravi LimitedFibrin rich / soft clot mechanical thrombectomy device
US12029442B2 (en)2021-01-142024-07-09Neuravi LimitedSystems and methods for a dual elongated member clot retrieval apparatus
WO2022164957A1 (en)2021-01-272022-08-04Galaxy Therapeutics, Inc.Systems and methods for treating aneurysms
US12064130B2 (en)2021-03-182024-08-20Neuravi LimitedVascular obstruction retrieval device having sliding cages pinch mechanism
US11963713B2 (en)2021-06-022024-04-23Covidien LpMedical treatment system
US11974764B2 (en)2021-06-042024-05-07Neuravi LimitedSelf-orienting rotating stentriever pinching cells
US11944374B2 (en)2021-08-302024-04-02Covidien LpElectrical signals for retrieval of material from vessel lumens
US12076020B2 (en)2021-11-182024-09-03Covidien LpRetrieval of material from corporeal lumens
US11844490B2 (en)2021-12-302023-12-19DePuy Synthes Products, Inc.Suture linkage for inhibiting premature embolic implant deployment

Family Cites Families (313)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4425908A (en)1981-10-221984-01-17Beth Israel HospitalBlood clot filter
SE445884B (en)1982-04-301986-07-28Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US5190546A (en)1983-10-141993-03-02Raychem CorporationMedical devices incorporating SIM alloy elements
FR2556210B1 (en)1983-12-081988-04-15Barra Jean Aubert VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME
US5749920A (en)1983-12-091998-05-12Endovascular Technologies, Inc.Multicapsule intraluminal grafting system and method
DK151404C (en)1984-05-231988-07-18Cook Europ Aps William FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD
WO1987004935A1 (en)1986-02-241987-08-27Fischell RobertAn intravascular stent and percutaneous insertion system
SE453258B (en)1986-04-211988-01-25Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
WO1988000813A1 (en)1986-08-051988-02-11St. Jude Medical, Inc.Braided polyester vascular prosthesis and method
FR2624747A1 (en)*1987-12-181989-06-23Delsanti Gerard REMOVABLE ENDO-ARTERIAL DEVICES FOR REPAIRING ARTERIAL WALL DECOLLEMENTS
US4921484A (en)*1988-07-251990-05-01Cordis CorporationMesh balloon catheter device
DE9010130U1 (en)1989-07-131990-09-13American Medical Systems, Inc., Minnetonka, Minn. Instrument for attaching an expansion implant
IE73670B1 (en)1989-10-021997-07-02Medtronic IncArticulated stent
US5545208A (en)1990-02-281996-08-13Medtronic, Inc.Intralumenal drug eluting prosthesis
US5122136A (en)1990-03-131992-06-16The Regents Of The University Of CaliforniaEndovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5221261A (en)1990-04-121993-06-22Schneider (Usa) Inc.Radially expandable fixation member
US5064435A (en)1990-06-281991-11-12Schneider (Usa) Inc.Self-expanding prosthesis having stable axial length
US5405379A (en)1990-07-261995-04-11Lane; Rodney J.Self expanding vascular endoprosthesis for aneurysms
US5222971A (en)1990-10-091993-06-29Scimed Life Systems, Inc.Temporary stent and methods for use and manufacture
USRE38711E1 (en)1991-03-082005-03-15Kabushikikaisha Igaki Iryo SekkeiLuminal stent, holding structure therefor and device for attaching luminal stent
USRE38653E1 (en)1991-03-082004-11-16Kabushikikaisha Igaki Iryo SekkeiLuminal stent, holding structure therefor and device for attaching luminal stent
US5766151A (en)1991-07-161998-06-16Heartport, Inc.Endovascular system for arresting the heart
US5232648A (en)1991-07-191993-08-03United States Surgical CorporationBioabsorbable melt spun fiber based on glycolide-containing copolymer
US5527338A (en)1992-09-021996-06-18Board Of Regents, The University Of Texas SystemIntravascular device
US5250071A (en)1992-09-221993-10-05Target Therapeutics, Inc.Detachable embolic coil assembly using interlocking clasps and method of use
DE59206251D1 (en)1992-10-311996-06-13Schneider Europ Ag Arrangement for implanting self-expanding endoprostheses
WO1994021170A1 (en)1993-03-161994-09-29Ep Technologies, Inc.Flexible circuit assemblies employing ribbon cable
US5476495A (en)1993-03-161995-12-19Ep Technologies, Inc.Cardiac mapping and ablation systems
US5334210A (en)*1993-04-091994-08-02Cook IncorporatedVascular occlusion assembly
RU2089131C1 (en)1993-12-281997-09-10Сергей Апполонович ПульневStent-expander
FR2714815B1 (en)1994-01-101996-03-08Microfil Ind Sa Elastic prosthesis to widen a duct, in particular a blood vessel.
US5549635A (en)1994-01-241996-08-27Solar, Rita & Gaterud, Ltd.Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore
US20030032963A1 (en)2001-10-242003-02-13Kyphon Inc.Devices and methods using an expandable body with internal restraint for compressing cancellous bone
AU1938395A (en)1994-03-041995-09-18Mentor CorporationSelf-sealing injection sites and method of manufacture
US5634942A (en)1994-04-211997-06-03B. Braun CelsaAssembly comprising a blood filter for temporary or definitive use and a device for implanting it
US5846261A (en)1994-07-081998-12-08Aga Medical Corp.Percutaneous catheter directed occlusion devices
US6123715A (en)1994-07-082000-09-26Amplatz; CurtisMethod of forming medical devices; intravascular occlusion devices
US5725552A (en)*1994-07-081998-03-10Aga Medical CorporationPercutaneous catheter directed intravascular occlusion devices
ES2340142T3 (en)1994-07-082010-05-31Ev3 Inc. SYSTEM TO CARRY OUT AN INTRAVASCULAR PROCEDURE.
US5690671A (en)1994-12-131997-11-25Micro Interventional Systems, Inc.Embolic elements and methods and apparatus for their delivery
US5879366A (en)1996-12-201999-03-09W.L. Gore & Associates, Inc.Self-expanding defect closure device and method of making and using
US5814062A (en)1994-12-221998-09-29Target Therapeutics, Inc.Implant delivery assembly with expandable coupling/decoupling mechanism
BE1009278A3 (en)1995-04-121997-01-07Corvita EuropGuardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
US5645558A (en)1995-04-201997-07-08Medical University Of South CarolinaAnatomically shaped vasoocclusive device and method of making the same
US5911731A (en)1995-04-201999-06-15Target Therapeutics, Inc.Anatomically shaped vasoocclusive devices
NO962336L (en)1995-06-061996-12-09Target Therapeutics Inc Vaso-occlusive spiral
US5624461A (en)1995-06-061997-04-29Target Therapeutics, Inc.Three dimensional in-filling vaso-occlusive coils
US5758562A (en)1995-10-111998-06-02Schneider (Usa) Inc.Process for manufacturing braided composite prosthesis
US6689162B1 (en)1995-10-112004-02-10Boston Scientific Scimed, Inc.Braided composite prosthesis
ATE177928T1 (en)1995-11-141999-04-15Schneider Europ Gmbh DEVICE FOR STENT IMPLANTATION
WO1997025918A1 (en)1996-01-191997-07-24Ep Technologies, Inc.Electrode structures formed from flexible, porous, or woven materials
US6168622B1 (en)*1996-01-242001-01-02Microvena CorporationMethod and apparatus for occluding aneurysms
CN1216929A (en)1996-02-021999-05-19血管转换公司Method and apparatus for blocking flow through blood vessels
US5733294A (en)1996-02-281998-03-31B. Braun Medical, Inc.Self expanding cardiovascular occlusion device, method of using and method of making the same
JP3804690B2 (en)1996-03-112006-08-02鹿島塩ビモノマー株式会社 Heat recovery method and heat recovery apparatus in thermal decomposition process of 1,2-dichloroethane
US5853422A (en)1996-03-221998-12-29Scimed Life Systems, Inc.Apparatus and method for closing a septal defect
AR001590A1 (en)1996-04-101997-11-26Jorge Alberto Baccaro Abnormal vascular communications occluder device and applicator cartridge of said device
US5718159A (en)*1996-04-301998-02-17Schneider (Usa) Inc.Process for manufacturing three-dimensional braided covered stent
US6440088B1 (en)1996-05-242002-08-27Precision Vascular Systems, Inc.Hybrid catheter guide wire apparatus and method
US6666883B1 (en)1996-06-062003-12-23Jacques SeguinEndoprosthesis for vascular bifurcation
US6190402B1 (en)1996-06-212001-02-20Musc Foundation For Research DevelopmentInsitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US6077295A (en)1996-07-152000-06-20Advanced Cardiovascular Systems, Inc.Self-expanding stent delivery system
US6096034A (en)1996-07-262000-08-01Target Therapeutics, Inc.Aneurysm closure device assembly
US5980514A (en)1996-07-261999-11-09Target Therapeutics, Inc.Aneurysm closure device assembly
US5941249A (en)1996-09-051999-08-24Maynard; Ronald S.Distributed activator for a two-dimensional shape memory alloy
WO1998012660A1 (en)1996-09-231998-03-26Psc Scanning, Inc.Dithering assemblies for barcode scanners
US5957974A (en)1997-01-231999-09-28Schneider (Usa) IncStent graft with braided polymeric sleeve
US6096073A (en)1997-02-252000-08-01Scimed Life Systems, Inc.Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
US5830230A (en)1997-03-071998-11-03Micro Therapeutics, Inc.Method of intracranial vascular embolotherapy using self anchoring coils
US5980554A (en)1997-05-051999-11-09Micro Therapeutics, Inc.Wire frame partial flow obstruction for aneurysm treatment
US5951599A (en)1997-07-091999-09-14Scimed Life Systems, Inc.Occlusion system for endovascular treatment of an aneurysm
US7569066B2 (en)1997-07-102009-08-04Boston Scientific Scimed, Inc.Methods and devices for the treatment of aneurysms
US5928260A (en)1997-07-101999-07-27Scimed Life Systems, Inc.Removable occlusion system for aneurysm neck
GB9715241D0 (en)1997-07-181997-09-24Jeffree Martin ADevice for treating aneurysms
EP1006890B1 (en)1997-08-042006-09-20Boston Scientific LimitedOcclusion system for aneurysm repair
WO1999008607A1 (en)*1997-08-051999-02-25Boston Scientific LimitedDetachable aneurysm neck bridge
US6063070A (en)*1997-08-052000-05-16Target Therapeutics, Inc.Detachable aneurysm neck bridge (II)
US5916235A (en)1997-08-131999-06-29The Regents Of The University Of CaliforniaApparatus and method for the use of detachable coils in vascular aneurysms and body cavities
US6086577A (en)*1997-08-132000-07-11Scimed Life Systems, Inc.Detachable aneurysm neck bridge (III)
US6860893B2 (en)1997-08-292005-03-01Boston Scientific Scimed, Inc.Stable coil designs
US6322576B1 (en)1997-08-292001-11-27Target Therapeutics, Inc.Stable coil designs
US6511468B1 (en)*1997-10-172003-01-28Micro Therapeutics, Inc.Device and method for controlling injection of liquid embolic composition
EP1028670B1 (en)1997-11-072008-01-02Salviac LimitedAn embolic protection device
US6443972B1 (en)1997-11-192002-09-03Cordis Europa N.V.Vascular filter
US6036720A (en)*1997-12-152000-03-14Target Therapeutics, Inc.Sheet metal aneurysm neck bridge
US6626939B1 (en)1997-12-182003-09-30Boston Scientific Scimed, Inc.Stent-graft with bioabsorbable structural support
US5873907A (en)1998-01-271999-02-23Endotex Interventional Systems, Inc.Electrolytic stent delivery system and methods of use
US7070607B2 (en)1998-01-272006-07-04The Regents Of The University Of CaliforniaBioabsorbable polymeric implants and a method of using the same to create occlusions
US20070093889A1 (en)1999-01-272007-04-26Wu Benjamin MNon-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy
US5944738A (en)*1998-02-061999-08-31Aga Medical CorporationPercutaneous catheter directed constricting occlusion device
JP2003522550A (en)1998-02-102003-07-29アーテミス・メディカル・インコーポレイテッド Occlusion, fixation, tensioning, and diverting devices and methods of use
DE69929036T2 (en)1998-02-122006-08-31Thomas R. North Vancouver Marotta ENDOVASCULAR PROSTHESIS
US6676696B1 (en)1998-02-122004-01-13Thomas R. MarottaEndovascular prosthesis
US5925060A (en)*1998-03-131999-07-20B. Braun CelsaCovered self-expanding vascular occlusion device
US6063111A (en)1998-03-312000-05-16Cordis CorporationStent aneurysm treatment system and method
US6007557A (en)*1998-04-291999-12-28Embol-X, Inc.Adjustable blood filtration system
US6168615B1 (en)1998-05-042001-01-02Micrus CorporationMethod and apparatus for occlusion and reinforcement of aneurysms
CA2333761C (en)1998-06-012008-05-27Kyphon Inc.Expandable preformed structures for deployment in interior body regions
AU756080B2 (en)1998-06-042003-01-02New York UniversityEndovascular thin film devices and methods for treating and preventing stroke
US6139564A (en)1998-06-162000-10-31Target Therapeutics Inc.Minimally occlusive flow disruptor stent for bridging aneurysm necks
US5935148A (en)*1998-06-241999-08-10Target Therapeutics, Inc.Detachable, varying flexibility, aneurysm neck bridge
US6165193A (en)*1998-07-062000-12-26Microvention, Inc.Vascular embolization with an expansible implant
US6093199A (en)*1998-08-052000-07-25Endovascular Technologies, Inc.Intra-luminal device for treatment of body cavities and lumens and method of use
US7410482B2 (en)1998-09-042008-08-12Boston Scientific-Scimed, Inc.Detachable aneurysm neck bridge
EP1109499B1 (en)1998-09-042007-08-15Boston Scientific LimitedDetachable aneurysm neck closure patch
US7128073B1 (en)1998-11-062006-10-31Ev3 Endovascular, Inc.Method and device for left atrial appendage occlusion
US6152144A (en)1998-11-062000-11-28Appriva Medical, Inc.Method and device for left atrial appendage occlusion
US6569179B2 (en)1998-11-102003-05-27Scimed Life Systems, Inc.Bioactive three loop coil
US6723112B2 (en)1998-11-102004-04-20Scimed Life Systems, Inc.Bioactive three loop coil
US6325820B1 (en)1998-11-162001-12-04Endotex Interventional Systems, Inc.Coiled-sheet stent-graft with exo-skeleton
US7018401B1 (en)1999-02-012006-03-28Board Of Regents, The University Of Texas SystemWoven intravascular devices and methods for making the same and apparatus for delivery of the same
CA2360168C (en)1999-02-012008-10-14Hideki HyodohWoven bifurcated and trifurcated stents and methods for making the same
US6695876B1 (en)1999-02-122004-02-24Thomas R. MarottaEndovascular prosthesis
US6368338B1 (en)1999-03-052002-04-09Board Of Regents, The University Of TexasOcclusion method and apparatus
US6428558B1 (en)*1999-03-102002-08-06Cordis CorporationAneurysm embolization device
US6613074B1 (en)1999-03-102003-09-02Cordis CorporationEndovascular aneurysm embolization device
US6682505B2 (en)1999-03-122004-01-27Arteria Medical Science, Inc.Catheter for removing emboli from saphenous vein grafts and native coronary arteries
US6585756B1 (en)1999-05-142003-07-01Ernst P. StreckerImplantable lumen prosthesis
US6375676B1 (en)1999-05-172002-04-23Advanced Cardiovascular Systems, Inc.Self-expanding stent with enhanced delivery precision and stent delivery system
JP4299973B2 (en)1999-05-202009-07-22ボストン サイエンティフィック リミテッド Stent delivery system with a shrink stabilizer
US6375668B1 (en)*1999-06-022002-04-23Hanson S. GiffordDevices and methods for treating vascular malformations
US20020169473A1 (en)1999-06-022002-11-14Concentric Medical, Inc.Devices and methods for treating vascular malformations
US6309367B1 (en)1999-07-232001-10-30Neurovasx, Inc.Aneurysm shield
US6689150B1 (en)1999-10-272004-02-10Atritech, Inc.Filter apparatus for ostium of left atrial appendage
US6652555B1 (en)1999-10-272003-11-25Atritech, Inc.Barrier device for covering the ostium of left atrial appendage
US6551303B1 (en)1999-10-272003-04-22Atritech, Inc.Barrier device for ostium of left atrial appendage
US6994092B2 (en)1999-11-082006-02-07Ev3 Sunnyvale, Inc.Device for containing embolic material in the LAA having a plurality of tissue retention structures
US6331184B1 (en)1999-12-102001-12-18Scimed Life Systems, Inc.Detachable covering for an implantable medical device
US6312458B1 (en)2000-01-192001-11-06Scimed Life Systems, Inc.Tubular structure/stent/stent securement member
US6350270B1 (en)2000-01-242002-02-26Scimed Life Systems, Inc.Aneurysm liner
US20020043456A1 (en)*2000-02-292002-04-18Ho Ken K.Bimorphic, compositionally-graded, sputter-deposited, thin film shape memory device
US6346117B1 (en)*2000-03-022002-02-12Prodesco, Inc.Bag for use in the intravascular treatment of saccular aneurysms
US6391037B1 (en)2000-03-022002-05-21Prodesco, Inc.Bag for use in the intravascular treatment of saccular aneurysms
US6632241B1 (en)2000-03-222003-10-14Endovascular Technologies, Inc.Self-expanding, pseudo-braided intravascular device
US6530934B1 (en)2000-06-062003-03-11Sarcos LcEmbolic device composed of a linear sequence of miniature beads
AU2001275376A1 (en)2000-06-082001-12-17John J FrantzenRadially expandable stent featuring covering tip primarily for bifurcated arteryaneurysms
WO2002000139A1 (en)2000-06-232002-01-03Frantzen John JRadially expandable aneurysm treatment stent
US8298257B2 (en)2000-06-292012-10-30Concentric Medical, Inc.Systems, methods and devices for removing obstructions from a blood vessel
US6855154B2 (en)2000-08-112005-02-15University Of Louisville Research Foundation, Inc.Endovascular aneurysm treatment device and method
US6969401B1 (en)2000-08-182005-11-29Marotta Thomas REndovascular prosthesis
US6635069B1 (en)2000-10-182003-10-21Scimed Life Systems, Inc.Non-overlapping spherical three-dimensional coil
US6589265B1 (en)*2000-10-312003-07-08Endovascular Technologies, Inc.Intrasaccular embolic device
BE1013757A6 (en)2000-12-122002-07-02Frid NoureddineLuminal endoprosthesis MODULAR.
US8192484B2 (en)2000-12-122012-06-05Cardiatis S.A.Stent for blood flow improvement
US6547804B2 (en)2000-12-272003-04-15Scimed Life Systems, Inc.Selectively permeable highly distensible occlusion balloon
US6699274B2 (en)2001-01-222004-03-02Scimed Life Systems, Inc.Stent delivery system and method of manufacturing same
JP4673987B2 (en)2001-02-272011-04-20株式会社トップ Stent and stent member
IL157732A0 (en)2001-03-082004-03-28Atritech IncAtrial filter implants
US6855153B2 (en)*2001-05-012005-02-15Vahid SaadatEmbolic balloon
US6814739B2 (en)2001-05-182004-11-09U.S. Endoscopy Group, Inc.Retrieval device
US6797083B2 (en)2001-06-112004-09-28Ev3 Inc.Method of training nitinol wire
US6692510B2 (en)2001-06-142004-02-17Cordis Neurovascular, Inc.Aneurysm embolization device and deployment system
US6454780B1 (en)2001-06-212002-09-24Scimed Life Systems, Inc.Aneurysm neck obstruction device
US20030100945A1 (en)*2001-11-232003-05-29Mindguard Ltd.Implantable intraluminal device and method of using same in treating aneurysms
US7011671B2 (en)*2001-07-182006-03-14Atritech, Inc.Cardiac implant device tether system and method
US8252040B2 (en)2001-07-202012-08-28Microvention, Inc.Aneurysm treatment device and method of use
US7572288B2 (en)2001-07-202009-08-11Microvention, Inc.Aneurysm treatment device and method of use
US8715312B2 (en)*2001-07-202014-05-06Microvention, Inc.Aneurysm treatment device and method of use
FR2828091B1 (en)2001-07-312003-11-21Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US20030028209A1 (en)2001-07-312003-02-06Clifford TeohExpandable body cavity liner device
US7485088B2 (en)2001-09-052009-02-03Chase Medical L.P.Method and device for percutaneous surgical ventricular repair
US6802851B2 (en)2001-09-202004-10-12Gordia Neurovascular, Inc.Stent aneurysm embolization method using collapsible member and embolic coils
US6811560B2 (en)2001-09-202004-11-02Cordis Neurovascular, Inc.Stent aneurysm embolization method and device
JP2003190175A (en)2001-11-152003-07-08Cordis Neurovascular IncAneurysm neck cover for sealing aneurysm
JP4429589B2 (en)2001-11-152010-03-10コーディス・ニューロバスキュラー・インコーポレイテッド Aneurysm embolization device using an occluding member
US20060292206A1 (en)2001-11-262006-12-28Kim Steven WDevices and methods for treatment of vascular aneurysms
US6723116B2 (en)2002-01-142004-04-20Syde A. TaheriExclusion of ascending/descending aorta and/or aortic arch aneurysm
US6989024B2 (en)2002-02-282006-01-24Counter Clockwise, Inc.Guidewire loaded stent for delivery through a catheter
US20030176884A1 (en)*2002-03-122003-09-18Marwane BerradaEverted filter device
US7695488B2 (en)2002-03-272010-04-13Boston Scientific Scimed, Inc.Expandable body cavity liner device
US20030195609A1 (en)2002-04-102003-10-16Scimed Life Systems, Inc.Hybrid stent
US20030195553A1 (en)*2002-04-122003-10-16Scimed Life Systems, Inc.System and method for retaining vaso-occlusive devices within an aneurysm
US6698877B2 (en)2002-06-282004-03-02Kimberly-Clark Worldwide, Inc.Offset printing apparatus for applying a substance
US20040172056A1 (en)2002-07-122004-09-02Guterman Lee R.Bifurcated aneurysm buttress arrangement
US6746890B2 (en)2002-07-172004-06-08Tini Alloy CompanyThree dimensional thin film devices and methods of fabrication
JP2004049585A (en)2002-07-222004-02-19Piolax Medical Device:Kk Stent type treatment device
US20040015224A1 (en)2002-07-222004-01-22Armstrong Joseph R.Endoluminal expansion system
US20040034386A1 (en)2002-08-192004-02-19Michael FultonAneurysm stent
US8075585B2 (en)2002-08-292011-12-13Stryker CorporationDevice and method for treatment of a vascular defect
US20040044391A1 (en)*2002-08-292004-03-04Stephen PorterDevice for closure of a vascular defect and method of treating the same
US7063679B2 (en)2002-09-202006-06-20Flowmedica, Inc.Intra-aortic renal delivery catheter
FR2847155B1 (en)2002-11-202005-08-05Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
US20040111112A1 (en)2002-11-202004-06-10Hoffmann Gerard VonMethod and apparatus for retaining embolic material
AU2003283792A1 (en)*2002-11-292004-06-23Mindguard Ltd.Braided intraluminal device for stroke prevention
US7169177B2 (en)*2003-01-152007-01-30Boston Scientific Scimed, Inc.Bifurcated stent
US20040143286A1 (en)2003-01-172004-07-22Johnson Eric G.Catheter with disruptable guidewire channel
US7744583B2 (en)2003-02-032010-06-29Boston Scientific ScimedSystems and methods of de-endothelialization
US20040193141A1 (en)2003-02-142004-09-30Leopold Eric W.Intravascular flow modifier and reinforcement device and deployment system for same
US20040193246A1 (en)2003-03-252004-09-30Microvention, Inc.Methods and apparatus for treating aneurysms and other vascular defects
US7597704B2 (en)2003-04-282009-10-06Atritech, Inc.Left atrial appendage occlusion device with active expansion
AU2004241870B2 (en)2003-05-232009-11-05Kabushikikaisha Igaki Iryo SekkeiStent supplying device
US7470282B2 (en)2003-06-302008-12-30Boston Scientific Scimed, Inc.Stent grip and system for use therewith
DE10335649A1 (en)2003-07-302005-02-24Jotec Gmbh Braid stent for implantation in a blood vessel
JP2007020590A (en)2003-08-192007-02-01Institute Of Physical & Chemical Research Aneurysm treatment material
US20050060017A1 (en)2003-09-152005-03-17Fischell Robert E.Means and method for the treatment of cerebral aneurysms
US7232461B2 (en)*2003-10-292007-06-19Cordis Neurovascular, Inc.Neck covering device for an aneurysm
US20050107867A1 (en)*2003-11-172005-05-19Taheri Syde A.Temporary absorbable venous occlusive stent and superficial vein treatment method
US20050107823A1 (en)*2003-11-192005-05-19Leone Jim E.Anchored stent and occlusive device for treatment of aneurysms
US7763011B2 (en)2003-12-222010-07-27Boston Scientific Scimed, Inc.Variable density braid stent
US8211140B2 (en)2004-01-222012-07-03Rex Medical, L.P.Vein filter
US20110208233A1 (en)2004-01-222011-08-25Mcguckin Jr James FDevice for preventing clot migration from left atrial appendage
US8398670B2 (en)2004-03-192013-03-19Aga Medical CorporationMulti-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US20050228434A1 (en)2004-03-192005-10-13Aga Medical CorporationMulti-layer braided structures for occluding vascular defects
US8777974B2 (en)2004-03-192014-07-15Aga Medical CorporationMulti-layer braided structures for occluding vascular defects
WO2005094725A1 (en)2004-03-312005-10-13Merlin Md Pte LtdA method for treating aneurysms
JP4395519B2 (en)2004-04-082010-01-13エイジーエイ メディカル コーポレイション Flange closure device and method
EP1748732A1 (en)2004-05-072007-02-07NMT Medical, Inc.Catching mechanisms for tubular septal occluder
CA2565106C (en)2004-05-252013-11-05Chestnut Medical Technologies, Inc.Flexible vascular occluding device
US8617234B2 (en)2004-05-252013-12-31Covidien LpFlexible vascular occluding device
US20060206200A1 (en)2004-05-252006-09-14Chestnut Medical Technologies, Inc.Flexible vascular occluding device
US8267985B2 (en)2005-05-252012-09-18Tyco Healthcare Group LpSystem and method for delivering and deploying an occluding device within a vessel
BE1016067A3 (en)2004-06-032006-02-07Frid NoureddineLuminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT.
US7699056B2 (en)2004-06-102010-04-20Conceptus, Inc.Medical devices and methods of making and using such devices
US20060025801A1 (en)2004-07-302006-02-02Robert LuloEmbolic device deployment system with filament release
CA2595809A1 (en)2004-08-312006-03-09Cook IncorporatedDevice for treating an aneurysm
EP2468348B1 (en)2004-09-172016-10-26Codman & Shurtleff, Inc.Thin film metallic devices for plugging aneurysms or vessels
CA2580752C (en)2004-09-172014-11-25Cordis Neurovascular, Inc.Vascular occlusion device with an embolic mesh ribbon
WO2006034153A2 (en)*2004-09-172006-03-30Cordis Neurovascular, Inc.Thin film metallic devices for plugging aneurysms or vessels
WO2006052322A2 (en)2004-09-222006-05-18Guterman Lee RCranial aneurysm treatment arrangement
US20060106421A1 (en)2004-11-162006-05-18Clifford TeohExpansible neck bridge
US20060116713A1 (en)2004-11-262006-06-01Ivan SepetkaAneurysm treatment devices and methods
US20060116714A1 (en)2004-11-262006-06-01Ivan SepetkaCoupling and release devices and methods for their assembly and use
US7608089B2 (en)2004-12-222009-10-27Boston Scientific Scimed, Inc.Vaso-occlusive device having pivotable coupling
US20060155323A1 (en)*2005-01-072006-07-13Porter Stephen CIntra-aneurysm devices
US20060167494A1 (en)2005-01-212006-07-27Loubert SuddabyAneurysm repair method and apparatus
US7601160B2 (en)2005-02-042009-10-13Zuli Holdings, LtdDevice and methods for non-surgical clipping of aneurysms
US20060190070A1 (en)2005-02-232006-08-24Dieck Martin SRail stent and methods of use
US20080219533A1 (en)2005-03-072008-09-11Koninklijke Philips Electronics, N.V.Apparatus and Method For Correlating First and Second 3D Images of Tubular Object
US20060206199A1 (en)2005-03-122006-09-14Churchwell Stacey DAneurysm treatment devices
US20060264905A1 (en)2005-05-022006-11-23Pulsar Vascular, Inc.Improved Catheters
WO2006119422A2 (en)2005-05-022006-11-09Pulsar Vascular, IncorporatedImproved catheters
US20060264907A1 (en)2005-05-022006-11-23Pulsar Vascular, Inc.Catheters having stiffening mechanisms
US8287535B2 (en)2005-05-112012-10-16Mayo Foundation For Medical Education And ResearchApparatus and methods for internal surgical procedures
AU2005332044B2 (en)2005-05-252012-01-19Covidien LpSystem and method for delivering and deploying and occluding device within a vessel
US7708754B2 (en)2005-06-022010-05-04Codman & Shurtleff, PcStretch resistant embolic coil delivery system with mechanical release mechanism
US20060276826A1 (en)2005-06-022006-12-07Vladimir MitelbergStretch resistant embolic coil delivery system with mechanical release mechanism
US7963988B2 (en)2005-06-232011-06-21Boston Scientific Scimed, Inc.ePTFE lamination—resizing ePTFE tubing
US20080114439A1 (en)2005-06-282008-05-15Venkatesh RamaiahNon-occluding dilation device
WO2007002863A2 (en)2005-06-282007-01-04Venkatesh RamaiahNon-occlusive, retrievable dilation system
US20080058856A1 (en)2005-06-282008-03-06Venkatesh RamaiahNon-occluding dilation device
WO2007013977A2 (en)*2005-07-212007-02-01The Research Foundation Of State University Of New YorkStent vascular intervention device and methods for treating aneurysms
FR2890306B1 (en)2005-09-082007-11-02Beatrix Jean DEVICE FOR THE TREATMENT OF A VASCULAR POCKET
US7972359B2 (en)2005-09-162011-07-05Atritech, Inc.Intracardiac cage and method of delivering same
US7550053B2 (en)2006-01-262009-06-23Ilh, LlcCatheters with lubricious linings and methods for making and using them
WO2007039678A1 (en)2005-10-052007-04-12Balt ExtrusionSafety catheter for fluid injection
US8545530B2 (en)2005-10-192013-10-01Pulsar Vascular, Inc.Implantable aneurysm closure systems and methods
EP1951129B1 (en)2005-10-192012-11-21Pulsar Vascular, Inc.Methods and systems for endovascularly clipping and repairing lumen and tissue defects
CA2627554A1 (en)2005-10-272007-05-03Martin S. DieckPartially covered stent devices and methods of use
US20070135826A1 (en)*2005-12-012007-06-14Steve ZaverMethod and apparatus for delivering an implant without bias to a left atrial appendage
WO2007076480A2 (en)2005-12-232007-07-05Levy Elad IBifurcated aneurysm treatment arrangement
US7744652B2 (en)2006-01-232010-06-29Hesham MorsiAneurysm sealing device
US7691124B2 (en)2006-01-312010-04-06Codman & Shurtleff, Inc.Delivery of therapeutic devices
US8157837B2 (en)2006-03-132012-04-17Pneumrx, Inc.Minimally invasive lung volume reduction device and method
AU2007309715A1 (en)2006-03-242008-05-02Biomerix CorpSelf-expandable endovascular device for aneurysm occlusion
DE102006013770A1 (en)2006-03-242007-09-27Occlutech Gmbh Occlusion instrument and method for its production
US20070233244A1 (en)2006-03-282007-10-04Depuy Spine, Inc.Artificial Disc Replacement Using Posterior Approach
JP5061181B2 (en)2006-04-072012-10-31ピナンブラ、インク System and method for occluding an aneurysm
JP5230602B2 (en)2006-04-172013-07-10タイコ ヘルスケア グループ リミテッド パートナーシップ System and method for mechanically positioning an endovascular implant
US8777979B2 (en)2006-04-172014-07-15Covidien LpSystem and method for mechanically positioning intravascular implants
EP1849440A1 (en)2006-04-282007-10-31Younes BoudjemlineVascular stents with varying diameter
US20070288083A1 (en)2006-05-122007-12-13Hines Richard AExclusion Device and System For Delivery
US7906066B2 (en)2006-06-302011-03-15Abbott Cardiovascular Systems, Inc.Method of making a balloon catheter shaft having high strength and flexibility
CN101495069A (en)2006-07-072009-07-29波士顿科学有限公司Endoprosthesis delivery system with stent holder
CA2660851A1 (en)2006-08-172008-02-21Nfocus Neuromedical, Inc.Isolation devices for the treatment of aneurysms
US20080114436A1 (en)2006-08-172008-05-15Dieck Martin SAneurysm covering devices and delivery devices
US8460335B2 (en)2006-09-112013-06-11Embrella Cardiovascular, Inc.Method of deflecting emboli from the cerebral circulation
US8372114B2 (en)2006-11-132013-02-12Electroformed Stents, Inc.Over-the-wire exclusion device and system for delivery
EP2263605A1 (en)*2006-11-202010-12-22SeptRx, Inc.Device and method for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool
US20080281350A1 (en)*2006-12-132008-11-13Biomerix CorporationAneurysm Occlusion Devices
US20080154286A1 (en)2006-12-212008-06-26Ryan AbbottSystems and Methods for Treating Septal Defects with Capture Devices and Other Devices
US9005242B2 (en)2007-04-052015-04-14W.L. Gore & Associates, Inc.Septal closure device with centering mechanism
US20110022149A1 (en)2007-06-042011-01-27Cox Brian JMethods and devices for treatment of vascular defects
WO2008157507A2 (en)2007-06-152008-12-24Nfocus Neuromedical, Inc.Blood flow diverters and aneurysm covering devices
US20080319533A1 (en)2007-06-222008-12-25Neurovasx, Inc.Aneurysm occlusion assist device
US20090112251A1 (en)2007-07-252009-04-30Aga Medical CorporationBraided occlusion device having repeating expanded volume segments separated by articulation segments
US8361138B2 (en)2007-07-252013-01-29Aga Medical CorporationBraided occlusion device having repeating expanded volume segments separated by articulation segments
EP2190380A1 (en)2007-09-112010-06-02NFocus Neuromedical, Inc.Aneurysm cover device for embolic delivery and retention
US20090082803A1 (en)*2007-09-262009-03-26Aga Medical CorporationBraided vascular devices having no end clamps
US9414842B2 (en)2007-10-122016-08-16St. Jude Medical, Cardiology Division, Inc.Multi-component vascular device
DE102008028308A1 (en)2007-10-182009-04-23Acandis Gmbh & Co. KgVascular implant for treating cerebral posterior circulation aneurysm, has lattice structure with deflection unit forming cone with apex that faces structure or three-dimensional curvature that extends towards axial end of structure
US20090118811A1 (en)2007-11-052009-05-07Medtronic Vascular, Inc.Globe Stent
JP2011505201A (en)2007-11-302011-02-24クック・インコーポレイテッド Method and apparatus for vascular therapy
WO2009076515A1 (en)2007-12-112009-06-18Cornell UniversityMethod and apparatus for sealing an opening in the side wall of a body lumen
US20100030220A1 (en)*2008-07-312010-02-04Dfine, Inc.Bone treatment systems and methods
US8163004B2 (en)2008-02-182012-04-24Aga Medical CorporationStent graft for reinforcement of vascular abnormalities and associated method
US20090228029A1 (en)2008-03-052009-09-10Neuro Vasx, Inc.Aneurysm shield anchoring device
EP2633823B1 (en)2008-04-212016-06-01Covidien LPBraid-ball embolic devices and delivery systems
US8974487B2 (en)2008-05-012015-03-10Aneuclose LlcAneurysm occlusion device
AU2009242528B2 (en)2008-05-022015-12-10Microvention, Inc.Filamentary devices for treatment of vascular defects
US8128617B2 (en)2008-05-272012-03-06Boston Scientific Scimed, Inc.Electrical mapping and cryo ablating with a balloon catheter
US7869889B2 (en)2008-07-022011-01-11Saudi Arabian Oil CompanyDistributed and adaptive smart logic with multi-communication apparatus for reliable safety system shutdown
US9179918B2 (en)2008-07-222015-11-10Covidien LpVascular remodeling device
WO2010028314A1 (en)2008-09-052010-03-11Pulsar Vascular, Inc.Systems and methods for supporting or occluding a physiological opening or cavity
US20100069948A1 (en)*2008-09-122010-03-18Micrus Endovascular CorporationSelf-expandable aneurysm filling device, system and method of placement
US20100131002A1 (en)2008-11-242010-05-27Connor Robert AStent with a net layer to embolize and aneurysm
JP5750051B2 (en)2009-01-222015-07-15コーネル ユニヴァーシティー Method and apparatus for restricting flow through a lumen wall
US20100274276A1 (en)2009-04-222010-10-28Ricky ChowAneurysm treatment system, device and method
US8657870B2 (en)2009-06-262014-02-25Biosensors International Group, Ltd.Implant delivery apparatus and methods with electrolytic release
BR112012010758A2 (en)2009-11-052019-09-24Sequent Medical Inc multilayer filament devices for treatment of vascular defects
US9814562B2 (en)2009-11-092017-11-14Covidien LpInterference-relief type delivery detachment systems
US9095342B2 (en)2009-11-092015-08-04Covidien LpBraid ball embolic device features
WO2011094634A1 (en)2010-01-282011-08-04Micro Therapeutics, Inc.Vascular remodeling device
WO2011094638A1 (en)2010-01-282011-08-04Micro Therapeutics, Inc.Vascular remodeling device
AU2011240927B2 (en)2010-04-142015-07-16Microvention, Inc.Implant delivery device
US20110301630A1 (en)2010-06-022011-12-08Cook IncorporatedOcclusion device
US8915950B2 (en)2010-12-062014-12-23Covidien LpVascular remodeling device
WO2012112749A2 (en)2011-02-182012-08-23Sequent Medical, Inc.Blood flow disruption devices and methods for the treatment of vascular defects
US20120245674A1 (en)2011-03-252012-09-27Tyco Healthcare Group LpVascular remodeling device
US20120283768A1 (en)2011-05-052012-11-08Sequent Medical Inc.Method and apparatus for the treatment of large and giant vascular defects
US20120330341A1 (en)2011-06-222012-12-27Becking Frank PFolded-Flat Aneurysm Embolization Devices
US9060886B2 (en)2011-09-292015-06-23Covidien LpVascular remodeling device
US8261648B1 (en)2011-10-172012-09-11Sequent Medical Inc.Braiding mechanism and methods of use
CN106192198B (en)2011-10-172020-06-05后续医疗股份有限公司Knitting mechanism

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references ofWO2011057277A2*

Cited By (19)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US11871931B2 (en)2014-08-082024-01-16DePuy Synthes Products, Inc.Embolic coil delivery system with retractable mechanical release mechanism
US11826051B2 (en)2017-12-212023-11-28DePuy Synthes Products, Inc.Implantable medical device detachment system with split tube and cylindrical coupling
US11147562B2 (en)2018-12-122021-10-19DePuy Synthes Products, Inc.Systems and methods for embolic implant detachment
US11253265B2 (en)2019-06-182022-02-22DePuy Synthes Products, Inc.Pull wire detachment for intravascular devices
US12419645B2 (en)2019-06-182025-09-23DePuy Synthes Products, Inc.Pull wire detachment for intravascular devices
US11207494B2 (en)2019-07-032021-12-28DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant distal portion
US11426174B2 (en)2019-10-032022-08-30DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant mechanical release
US12419646B2 (en)2019-10-032025-09-23DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant mechanical release
US11376013B2 (en)2019-11-182022-07-05DePuy Synthes Products, Inc.Implant delivery system with braid cup formation
US11457922B2 (en)2020-01-222022-10-04DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant distal portion
US11432822B2 (en)2020-02-142022-09-06DePuy Synthes Products, Inc.Intravascular implant deployment system
EP3865079A1 (en)*2020-02-142021-08-18DePuy Synthes Products, Inc.Intravascular implant deployment system
US11951026B2 (en)2020-06-302024-04-09DePuy Synthes Products, Inc.Implantable medical device detachment system with flexible braid section
US11937824B2 (en)2021-12-302024-03-26DePuy Synthes Products, Inc.Implant detachment systems with a modified pull wire
US12011171B2 (en)2022-01-062024-06-18DePuy Synthes Products, Inc.Systems and methods for inhibiting premature embolic implant deployment
US11937825B2 (en)2022-03-022024-03-26DePuy Synthes Products, Inc.Hook wire for preventing premature embolic implant detachment
US12137915B2 (en)2022-03-032024-11-12DePuy Synthes Products, Inc.Elongating wires for inhibiting premature implant detachment
US11937826B2 (en)2022-03-142024-03-26DePuy Synthes Products, Inc.Proximal link wire for preventing premature implant detachment
US12402886B2 (en)2022-06-232025-09-02DePuy Synthes Products, Inc.Detachment indicator for implant deployment

Also Published As

Publication numberPublication date
WO2011057277A3 (en)2011-07-28
CA2779483A1 (en)2011-05-12
WO2011057277A2 (en)2011-05-12
CN102791205A (en)2012-11-21
CN102791205B (en)2016-02-03
ES2534192T3 (en)2015-04-20
AU2010314871B2 (en)2014-10-30
US20110202085A1 (en)2011-08-18
JP5711251B2 (en)2015-04-30
US9095342B2 (en)2015-08-04
CA2779483C (en)2018-03-13
AU2010314871A1 (en)2012-05-31
JP2013509972A (en)2013-03-21
US20110319926A1 (en)2011-12-29
EP2498691B1 (en)2015-01-07

Similar Documents

PublicationPublication DateTitle
EP2498691B1 (en)Braid ball embolic device features
US9814562B2 (en)Interference-relief type delivery detachment systems
EP2387959B1 (en)Braid-ball embolic devices and delivery systems
WO2014152579A1 (en)Interference-relief type delivery detachment systems
HK1165976A (en)Braid-ball embolic devices and delivery systems
HK1171639A (en)Braid-ball embolic devices and delivery systems
HK1167306A (en)Braid-ball embolic devices and delivery systems
HK1171636A (en)Braid-ball embolic devices and delivery systems

Legal Events

DateCodeTitleDescription
PUAIPublic reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text:ORIGINAL CODE: 0009012

17PRequest for examination filed

Effective date:20120607

AKDesignated contracting states

Kind code of ref document:A2

Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17QFirst examination report despatched

Effective date:20130404

REGReference to a national code

Ref country code:HK

Ref legal event code:DE

Ref document number:1175387

Country of ref document:HK

RAP1Party data changed (applicant data changed or rights of an application transferred)

Owner name:COVIDIEN LP

GRAPDespatch of communication of intention to grant a patent

Free format text:ORIGINAL CODE: EPIDOSNIGR1

INTGIntention to grant announced

Effective date:20140714

RIN1Information on inventor provided before grant (corrected)

Inventor name:BECKING, FRANK P.

Inventor name:DE BEER, NICHOLAS C.

Inventor name:LOGANATHAN, SIDDHARTH

GRASGrant fee paid

Free format text:ORIGINAL CODE: EPIDOSNIGR3

GRAA(expected) grant

Free format text:ORIGINAL CODE: 0009210

AKDesignated contracting states

Kind code of ref document:B1

Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REGReference to a national code

Ref country code:GB

Ref legal event code:FG4D

REGReference to a national code

Ref country code:CH

Ref legal event code:EP

REGReference to a national code

Ref country code:IE

Ref legal event code:FG4D

REGReference to a national code

Ref country code:AT

Ref legal event code:REF

Ref document number:705134

Country of ref document:AT

Kind code of ref document:T

Effective date:20150215

REGReference to a national code

Ref country code:DE

Ref legal event code:R096

Ref document number:602010021683

Country of ref document:DE

Effective date:20150226

REGReference to a national code

Ref country code:ES

Ref legal event code:FG2A

Ref document number:2534192

Country of ref document:ES

Kind code of ref document:T3

Effective date:20150420

REGReference to a national code

Ref country code:NL

Ref legal event code:VDEP

Effective date:20150107

REGReference to a national code

Ref country code:AT

Ref legal event code:MK05

Ref document number:705134

Country of ref document:AT

Kind code of ref document:T

Effective date:20150107

REGReference to a national code

Ref country code:LT

Ref legal event code:MG4D

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:HR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:FI

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:SE

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:NO

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150407

Ref country code:BG

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150407

Ref country code:LT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:AT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:RS

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:IS

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150507

Ref country code:LV

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:NL

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:GR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150408

Ref country code:PL

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

REGReference to a national code

Ref country code:DE

Ref legal event code:R097

Ref document number:602010021683

Country of ref document:DE

REGReference to a national code

Ref country code:FR

Ref legal event code:PLFP

Year of fee payment:6

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:DK

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:EE

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:RO

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:SK

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:CZ

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PLBENo opposition filed within time limit

Free format text:ORIGINAL CODE: 0009261

STAAInformation on the status of an ep patent application or granted ep patent

Free format text:STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26NNo opposition filed

Effective date:20151008

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:SI

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:BE

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:MC

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:LU

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20151109

REGReference to a national code

Ref country code:CH

Ref legal event code:PL

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:CH

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20151130

Ref country code:LI

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20151130

REGReference to a national code

Ref country code:FR

Ref legal event code:PLFP

Year of fee payment:7

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:HU

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date:20101109

Ref country code:SM

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:CY

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:MT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:TR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

REGReference to a national code

Ref country code:FR

Ref legal event code:PLFP

Year of fee payment:8

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:PT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

Ref country code:MK

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

REGReference to a national code

Ref country code:FR

Ref legal event code:PLFP

Year of fee payment:9

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:AL

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20150107

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:ES

Payment date:20191202

Year of fee payment:10

Ref country code:IT

Payment date:20191021

Year of fee payment:10

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:GB

Payment date:20201021

Year of fee payment:11

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:IT

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20201109

REGReference to a national code

Ref country code:ES

Ref legal event code:FD2A

Effective date:20220201

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:ES

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20201110

GBPCGb: european patent ceased through non-payment of renewal fee

Effective date:20211109

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:GB

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20211109

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:DE

Payment date:20241022

Year of fee payment:15

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:FR

Payment date:20241022

Year of fee payment:15

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:IE

Payment date:20241023

Year of fee payment:15


[8]ページ先頭

©2009-2025 Movatter.jp